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Abstract
In Part I titled Empirical Bayes Estimation, we discuss the estimation of a heteroscedastic multivariate normal
mean in terms of the ensemble risk. We first derive the ensemble minimax properties of various estimators
that shrink towards zero through the empirical Bayes method. We then generalize our results to the case where
the variances are given as a common unknown but estimable chi-squared random variable scaled by different
known factors. We further provide a class of ensemble minimax estimators that shrink towards the common
mean. We also make comparison and show differences between results from the heteroscedastic case and
those from the homoscedastic model.
In Part II titled Causal Inference Analysis, we study the estimation of the causal effect of treatment on survival
probability up to a given time point among those subjects who would comply with the assignment to both
treatment and control when both administrative censoring and noncompliance occur. In many clinical studies
with a survival outcome, administrative censoring occurs when follow-up ends at a pre-specified date and
many subjects are still alive. An additional complication in some trials is that there is noncompliance with the
assigned treatment. We first discuss the standard instrumental variable method for survival outcomes and
parametric maximum likelihood methods, and then develop an efficient plug-in nonparametric empirical
maximum likelihood estimation (PNEMLE) approach. The PNEMLE method does not make any
assumptions on outcome distributions, and makes use of the mixture structure in the data to gain efficiency
over the standard instrumental variable method. Theoretical results of the PNEMLE are derived and the
method is illustrated by an analysis of data from a breast cancer screening trial. From our limited mortality
analysis with administrative censoring times 10 years into the follow-up, we find a significant benefit of
screening is present after 4 years (at the 5% level) and this persists at 10 years follow-up.
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ABSTRACT
STATISTICAL ANALYSIS IN EMPIRICAL BAYES AND IN CAUSAL
INFERENCE
Hui Nie
Lawrence Brown (Advisor)
In Part I titled Empirical Bayes Estimation, we discuss the estimation of a het-
eroscedastic multivariate normal mean in terms of the ensemble risk. We first
derive the ensemble minimax properties of various estimators that shrink towards
zero through the empirical Bayes method. We then generalize our results to the
case where the variances are given as a common unknown but estimable chi-squared
random variable scaled by different known factors. We further provide a class of
ensemble minimax estimators that shrink towards the common mean. We also make
comparison and show differences between results from the heteroscedastic case and
those from the homoscedastic model.
In Part II titled Causal Inference Analysis, we study the estimation of the causal
effect of treatment on survival probability up to a given time point among those
subjects who would comply with the assignment to both treatment and control
when both administrative censoring and noncompliance occur. In many clinical
vi
studies with a survival outcome, administrative censoring occurs when follow-up
ends at a pre-specified date and many subjects are still alive. An additional com-
plication in some trials is that there is noncompliance with the assigned treatment.
We first discuss the standard instrumental variable method for survival outcomes
and parametric maximum likelihood methods, and then develop an efficient plug-
in nonparametric empirical maximum likelihood estimation (PNEMLE) approach.
The PNEMLE method does not make any assumptions on outcome distributions,
and makes use of the mixture structure in the data to gain efficiency over the stan-
dard instrumental variable method. Theoretical results of the PNEMLE are derived
and the method is illustrated by an analysis of data from a breast cancer screening
trial. From our limited mortality analysis with administrative censoring times 10
years into the follow-up, we find a significant benefit of screening is present after 4
years (at the 5% level) and this persists at 10 years follow-up.
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Part I: Empirical Bayes Estimation
Ensemble Minimax Estimation for Multi-
variate Normal Means
1
Chapter 1
Introduction and Background
Knowledge
1.1 Estimation of Multivariate Normal Mean
We consider the problem of simultaneously estimating the mean parameter θ =
(θ1, · · · , θp) from independent normal observations X ∼ N(θ, Σ), where Σ is a
diagonal matrix with the elements {σ21, · · · , σ2p}. For any estimator θ̂, our loss
function is the ordinary squared error loss
L(θ̂, θ) =
p∑
i=1
(θ̂i − θi)2.
The conventional risk function is the expected value of the loss function with respect
to θ. That is,
R(θ, θ̂) = Eθ(L(θ̂, θ)) =
p∑
i=1
Eθ(θ̂i − θi)2.
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James and Stein (1961) study the homoscedastic case in which σ2 = σ21 = · · · =
σ2p. In that case they prove the astonishing result that the James-Stein shrinkage
estimator
δJ−S(X) =
(
1− Cσ
2
‖X‖2
)
X (1.1.1)
and its positive part
δ+J−S(X) =
(
1− Cσ
2
‖X‖2
)
+
X (1.1.2)
dominate the usual MLE δ0(X) = X for 0 ≤ C ≤ 2(p−2) and p ≥ 3. The discovery
by James and Stein has led to a wide application of shrinkage techniques in many
important problems. References include Efron and Morris (1975), Fay and Herriot
(1979), Rubin (1981), Morris (1983a), Green and Strawderman (1985), Jones (1991)
and Brown (2008). The theoretical properties of shrinkage estimators have also been
extensively studied in the literature under the homoscedastic Gaussian model. Since
Stein’s discovery, “shrinkage” has been developed as a broad statistical framework in
many aspects (Stein, 1962; Strawderman, 1971; Efron and Morris, 1971,1972a,1972b
and 1973; Casella, 1980; Hastie et al., 2003).
There is also some literature discussing the properties of the James-Stein shrink-
age estimators under heteroscedasticity. James and Stein (1961) discuss the esti-
mation problem under heteroscedasticity where the loss function is weighted by the
inverse of the variances. This problem can be transformed to the homoscedastic
case under ordinary squared error loss. Brown (1975) shows that the James-Stein
estimator is not always minimax and hence does not necessarily dominate the usual
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MLE under ordinary squared error loss when the variances are not equal. Specifi-
cally, the James-Stein shrinkage estimator does not dominate the usual MLE when
the largest variance is larger than the sum of the rest. Moreover, Casella (1980)
argues that the James-Stein shrinkage estimator may not be a desirable shrinkage
estimator under heteroscedasticity even if it is minimax. Minimax estimators in
general shrink most on the coordinates with smaller variances, while Bayes estima-
tors shrink most on large variance coordinates.
In many applications, θi are thought to follow some exchangeable prior distri-
bution π. It is then natural to consider the compound risk function which is then
the Bayes risk with respect to the prior π
R(π, θ̂) = Eπ(R(θ, θ̂)) =
∫
R(θ, θ̂)π(dθ).
Efron and Morris (1971, 1972a, 1972b and 1973) address this problem from both the
Bayes and empirical Bayes perspective. They extensively develop this framework.
Especially, they consider a prior distribution of the form θ ∼ Np(0, τ 2I) with τ 2 ∈
[0,∞), and they use the term “ensemble risk” for the compound risk. Morris and
Lysy (2009) discuss the motivation and importance of shrinkage estimation in this
multi-level normal model. The ensemble risk is described as the level-II risk in
Morris and Lysy (2009).
By introducing a set of ensemble risks R(π, θ̂) (π ∈ P), we can then discuss
ensemble minimaxity and other properties with respect to a set of prior distributions
P . We elaborate the definitions of ensemble minimaxity and other properties in
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Chapter 2. The previously cited papers (and others) discuss the desirability of the
ensemble risks with respect to the normal priors θ ∼ Np(0, τ 2I) with τ 2 ∈ [0,∞).
In this paper, we will concentrate on the ensemble minimaxity of various estimators
in this respect.
Brown (2008) discusses the connection between the parametric empirical Bayes
estimator and the random effects model. In fact, the estimation problem of group
means in a one way random effects model with infinite degrees of freedom for errors
(and hence known error variance) is equivalent to the above problem. Our ensemble
risk then corresponds to the ordinary risk function in the random effects model.
The more familiar unbalanced one-way random effects model is exactly equiv-
alent to the generalization considered in Section 4.2. Again, ensemble risk in the
empirical Bayes sense corresponds to ordinary prediction risk for the random ef-
fects model. We close Section 4.2 with a summary statement describing estimators
proven to dominate the ordinary least squares group means in the random effect
model.
1.2 Empirical Bayes Method
Empirical Bayes method is a powerful tool in statistical decision theory. It has a
very long history. Robbins (1951) propose a subminimax decision rule for the clas-
sification problem through empirical Bayes perspective. The key idea of empirical
Bayes method is that the underlying relationships among the coordinates of the
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parameters allow use of the observed data to estimate some features of the prior
distribution. The most obvious empirical Bayes problems are when the parameters
arise from some common population so that we can imagine creating a probabilistic
model for the population and also interpret this model as the prior distribution.
The simplest version of this situation is when the parameters are i.i.d. from some
prior distribution. Random effects models are one of this types of problems. Al-
though it uses the Bayesian idea, from the modeling perspective, empirical Bayes
problems can be considered to be problems in classical statistics.
Empirical Bayes methods can be categorized in two different ways. One division
is between parametric empirical Bayes and nonparametric empirical Bayes. In the
former, one assumes that the prior distribution of the parameters is in some para-
metric class with unknown hyperparameters. In the latter, one assumes only that
the parameters are i.i.d. A different categorization of empirical Bayes analysis is
given by its operational focus. The most natural focus is to use the data to estimate
the prior information or the posterior distribution. The subsequent analysis turns
to a typical Bayesian fashion once this is done. The other possible operational focus
is to represent the Bayes rule in terms of the unknown prior, and then use the data
to estimate the Bayes rule directly.
There is lots of previous literature discussing the application of empirical Bayes
methods in the theoretical estimation problems of multivariate normal means. Efron
and Morris (1971, 1972a, 1972b and 1973) give an interpretation of Stein’s (1962) as-
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tonishing results through Bayes and parametric empirical Bayes perspective. They
point out that the James-Stein estimator is an empirical Bayes estimator where
we use the observed data to estimate the Bayes rule, and they propose a class of
minimax empirical Bayes estimators that shrink towards common means instead
of zero. Strawderman (1971) proposes a class of minimax Bayes estimators with
respect to the harmonic prior. Casella (1980) derives conditions that are necessary
and sufficient for minimaxity of a large class of ridge regression estimators.
The discovery of the theoretical knowledge has also led to a wide application of
empirical Bayes methods in many important problems. Carter and Rolph (1974)
use empirical Bayes methods to estimate fire alarm possibilities. Efron and Morris
(1975) and Brown (2008) predict the batting averages of players in Major League
Baseball via empirical Bayes methods. Fay and Herriot (1979) estimate the income
for small places. Rubin (1981) apply empirical Bayes techniques in the law school
validity studies. Jones (1985) studies the house-price variation in Southampton.
Green and Strawderman (1985) use empirical Bayes estimation in individual tree
volume equation development.
In our paper, we use the idea of empirical Bayes methods to construct various
shrinkage estimators that have better properties than the usual maximum likelihood
estimator. Our judgement criteria is the “ensemble risk”, which will be defined in
the following chapter.
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Chapter 2
Definition of Ensemble
Minimaxity
As discussed above, we study in this paper the behavior of shrinkage estimators
based on the ensemble risk
R(π, θ̂) = Eπ(R(θ, θ̂)) =
∫
R(θ, θ̂)π(dθ) .
If the prior π(θ) is known, the resulting posterior mean Eπ(θ|x) is then the optimal
estimate under the sum of the squared error loss. However, it is often infeasible
to exactly specify the prior. To avoid excessive dependence on the choice of prior,
it is natural to consider a set of priors P on θ and study the properties of various
estimators based on the corresponding set of ensemble risks. As in the classic
decision theory, there rarely exists an estimator that achieves the minimum ensemble
risk uniformly for all π ∈ P . A more realistic goal as pursued in this paper is to
8
study the ensemble minimaxity (defined shortly) of familiar shrinkage estimators.
Recall that with ordinary risk R(θ, δ), an estimator δ is said to dominate another
estimator δ′ if
R(θ, δ) ≤ R(θ, δ′)
holds for each θ ∈ Θ with strict inequality for at least one θ. The estimator δ is
inadmissible if there exists another procedure which dominates δ; otherwise δ is
admissible. δ is said to be minimax if
sup
θ∈Θ
R(θ, δ) = inf
δ′
sup
θ∈Θ
R(θ, δ
′
) ,
that is, the estimator attains the minimum worst-case risk. Similarly for the case
of ensemble risk we have the following definitions.
Ensemble admissibility and minimaxity. Given a set of priors P , an estimator
δ is said to dominate another estimator δ′ with respect to P if
R(π, δ) ≤ R(π, δ′)
holds for each π ∈ P with strict inequality for at least one π. The estimator δ is
ensemble inadmissible with respect to P if there exists another procedure which
dominates δ, otherwise δ is ensemble admissible. The estimator δ is ensemble min-
imax with respect to P if
sup
π∈P
R(π, δ) = inf
δ
′
sup
π∈P
R(π, δ
′
) .
The motivation for the above definitions comes from the use of the empirical
Bayes methods in simultaneous inference. Efron and Morris (1972a), building from
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Stein (1962), derive the James-Stein estimator through the parametric empirical
Bayes model with θi ∼ N(0, τ 2). Note that in such an empirical Bayes model,
τ 2 is the unknown parameter. (Parameter here refers to an unknown non-random
quantity.) Ensemble admissibility and minimaxity with respect to P = {θi ∼
N(0, τ 2) : 0 < τ 2 < ∞} is then exactly the counterpart of ordinary admissibility
and minimaxity in the empirical Bayes model. Consistent with this, we also confine
P to be the one given above. Another reason for preferring such a set P is because it
enjoys the conjugate minimaxity property (Morris, 1983a). From now on, mention
of this underlying set P will be omitted whenever confusion is unlikely. As an
explicit notation in this setting, we define Rτ2(δ) = R(π, δ) for π = N(0, τ
2).
Note that ensemble minimaxity can also be interpreted as a particular case of
Gamma minimaxity studied in the context of robust Bayes analysis (Good, 1952;
Berger, 1979). However, in such studies, a “large” set consisting of many diffuse
priors are usually included in the analysis. Since this is quite different from our
formulation of the problem, we use the term ensemble minimaxity throughout our
paper, following the Efron and Morris papers cited above.
10
Chapter 3
Main Results on Ensemble
Minimaxity
In this chapter, we discuss the ensemble minimaxity of various shrinkage estima-
tors. We first present a general theorem characterizing a class of shrinkage esti-
mators that are ensemble minimax. We then study the ensemble minimaxity of
James-Stein-type shrinkage estimators, along with several supplementary theorems
highlighting the difference and similarity between our results and those obtained
in the homoscedastic case. Finally, we investigate the ensemble minimaxity of the
parametric empirical Bayes estimator via method of moment estimation, a case
with several open problems unresolved during our study. Throughout the current
discussion, the variances σ2i are assumed to be known; the case of unknown σ
2
i is
addressed in the next chapter.
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3.1 General Theory
As discussed in Section 1.1, when p ≥ 3 and 0 ≤ C ≤ 2(p − 2), both δJ−S in
(1.1.1) and δ+J−S in (1.1.2) are known to be minimax under the homoscedastic
model. However, this is not always the case under the heteroscedastic model. Brown
(1975) shows that for any C > 0, if
∑
σ2i ≤ 2 max{σ2i }, both δJ−S in (3.1.1) and
δ+J−S in (3.1.2) are no longer minimax in the ordinary sense. This is one motivation
for instead studying the ensemble minimaxity for these shrinkage estimators. The
following theorem shows that δ0(X) = X is ensemble minimax with respect to P .
Theorem 1. δ0 is ensemble minimax with respect to P.
Proof. See Chapter 6.
As we can see in Figure 3.1, δ0 has a constant ensemble risk for any prior in
P . Although δ0 is ensemble minimax, it is possible to construct a class of ensemble
minimax estimators that dominates δ0 with respect to P . Before presenting our
main result, we first give a lemma concerning the evaluation of the ensemble risk
Rτ2(δ) that will be repeatedly used in subsequent discussion.
Lemma 1. The ensemble risk of any estimator δ with the form δi(X) = (1 −
hi(X))Xi can be written as
Rτ2(δ) =
p∑
i=1
[
Ex
(
σ2i
τ 2 + σ2i
Xi − hi(X)Xi
)2
+
τ 2σ2i
τ 2 + σ2i
]
,
where the expectation is taken with respect to the joint distribution of X such that
Xi ∼ N(0, τ 2 + σ2i ) and all the coordinates are jointly independent.
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Figure 3.1: Ensemble Risk of δ0(X) = X
tau^2
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Proof. See Chapter 6.
Under the heteroscedastic model, we define the James-Stein-type estimator δJ−S
as
(δJ−S(X))i =
(
1− Cσ
2
i
‖X‖2
)
Xi . (3.1.1)
Its positive part δ+J−S is then
(δ+J−S(X))i =
(
1− Cσ
2
i
‖X‖2
)
+
Xi . (3.1.2)
Estimators of this general form appear as a generalization of the original James-
Stein proposal in Brown (1966). See also Efron and Morris (1971). To study the
ensemble minimaxity of these two estimators, we first present a general result that
characterizes a class of shrinkage estimators that are ensemble minimax.
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The general result refers to estimators with the form δi(X) = (1− hi(X))Xi, as
in Lemma 1, and in which hi is symmetric in the sense that
hi(X) = hi(X
2
1 , · · · , X2p ). (3.1.3)
In addition, we define
W =
p∑
j=1
X2j
τ 2 + σ2j
(3.1.4)
Ti =
X2i
W (τ 2 + σ2i )
, i = 1, · · · , p. (3.1.5)
In this way X2i = (τ
2 + σ2i )WTi, and h can be rewritten as a function of T =
(T1, · · · , Tp) and W . With a minor extension of the notation, write h(T ,W ) =
h((τ 2 + σ21)WT1, · · · , (τ 2 + σ2p)WTp).
Theorem 2. An estimator δ with the form δi(X) = (1 − hi(X))Xi is ensemble
minimax if each shrinkage factor hi(X) satisfies the following conditions:
(1) hi(X) ≥ 0, ∀X.
(2) hi(X) can be written in the form (3.1.3).
(3) hi(T ,W ) is decreasing in W for fixed T .
(4) hi(T ,W )W is increasing in W for fixed T .
(5)
E
[
sup
T
hi(T , W )
]
≤ 2σ
2
i
σ2i + τ
2
.
14
Proof. See Chapter 6.
Note that most of the conditions in Theorem 2 are rather intuitive to under-
stand. Condition (1) simply means that the estimator is indeed a genuine shrinkage
estimator, and never an expander. Condition (2) implies the shrinkage estimator
has a certain natural symmetry property. Condition (3) requires the amount of
shrinkage to decrease when the distance of the data vector is further away from the
origin. Condition (5) controls the expected overall amount of shrinkage according
to the ratio of the variability of the observation and that of the prior, but this
condition is less intuitive than the others.
Let µ ∈ Rp. Consider estimation of the linear combination µtθ under squared
error loss Llc(d, θ) = (d − µtθ)2. Ordinary minimaxity and ensemble minimaxity
can be defined for this loss. As a Corollary to Theorem 2, we have
Corollary 1. Assume conditions (1)-(5) of Theorem 2. Then the estimator η̂ = µtδ
is an ensemble minimax estimator of η = µtθ.
Proof. From the proof of Theorem 2, we see that ensemble minimaxity is actually
achieved for each coordinate, that is, for any i = 1, · · · , p,
Rlc(δi, θi) ≤ σ2i .
This proves validity of the corollary.
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3.2 James-Stein-type Shrinkage Estimators
With Theorem 2, we then proceed to study the ensemble minimaxity of certain
shrinkage estimators. These estimators include the original James-Stein estimators.
As we will show, the original James-Stein estimator is often but not always ensemble
minimax. Consider the estimator δGS with the form
(δGS(X))i =
(
1− λiσ
2
i
νiσ2i + ‖X‖2
)
Xi , (3.2.1)
where λi and νi are properly chosen constants. Consider also its positive part version
δ+GS given by
(δ+GS(X))i =
(
1− λiσ
2
i
νiσ2i + ‖X‖2
)
+
Xi . (3.2.2)
Note that these forms are generalizations of the original James-Stein forms, as can
be seen by setting νi = 0, λi = C.
The following two corollaries state conditions under which δGS in (3.2.1) and
δ+GS in (3.2.2) are ensemble minimax.
Corollary 2. δGS in (3.2.1) is ensemble minimax if p ≥ 3 and for any i = 1, · · · , p,
0 ≤ λi ≤ 2(p− 2) and νi ≥ (λi/2− (p− 2) · σ2min/σ2i )+ with σ2min = min
i
{σ2i }.
Proof. See Chapter 6.
Corollary 3. δ+GS in (3.2.2) is ensemble minimax if p ≥ 3 and for any i = 1, · · · , p,
0 ≤ λi ≤ 2(p− 2) and νi ≥ [λi − (p− 2)(1 + σ2min/σ2i )]+ with σ2min = min
i
{σ2i }.
Proof. See Chapter 6.
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Remarks: When νi = 0 and λi = C, δGS in (3.2.1) and δ
+
GS in (3.2.2) reduce to
the James-Stein estimators in (3.1.1) and (3.1.2). In the case where σ2i are all equal,
Corollary 2 and 3 show that δJ−S in (3.1.1) and δ+J−S in (3.1.2) are each ensemble
minimax when 0 ≤ C ≤ 2(p − 2). This reaches the same conclusion as James and
Stein (1961).
When the values of σ2i are not all equal, the results in Corollary 2 and 3 do not
always establish ensemble minimaxity of δJ−S in (3.1.1) and δ+J−S in (3.1.2) for the
entire range 0 ≤ C ≤ 2(p − 2). Specializing the conditions of Corollary 2 to the
case where λi = C and νi = 0 yields that δJ−S in (3.1.1) is ensemble minimax if
C ≤ 2(p− 2)σ
2
min
σ2max
. (3.2.3)
Thus, for any C > 0, there are configurations of σ21, · · · , σ2p for which the conditions
in Corollary 2 fail to prove δJ−S in (3.1.1) is ensemble minimax.
For δ+J−S in (3.1.2), the situation is a little different. Specializing the conditions
of Corollary 3 to the case λi = C and νi = 0 yields that δ
+
J−S in (3.1.2) is ensemble
minimax if
C ≤ (p− 2)(1 + σ
2
min
σ2max
). (3.2.4)
Hence, when C ≤ p− 2, the conditions in Corollary 3 are always satisfied by δ+J−S
in (3.1.2). However, for any C > p − 2, there are configurations of σ21, · · · , σ2p for
which Corollary 3 fails to prove δ+J−S in (3.1.2) is minimax.
Theorem 3 and 4 below address ensemble minimaxity of δJ−S in (3.1.1) when
C > 0 and δ+J−S in (3.1.2) when C > p − 2. They state conditions under which
17
Figure 3.2: Ensemble Risk of δ+J−S (Dash Line) and δ0(X) = X (Solid Line)
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δJ−S in (3.1.1) and δ+J−S in (3.1.2) can fail to be ensemble minimax when C > 0 or
C > p− 2, respectively. There is a gap between the conditions in Corollaries 2 and
3. We do not as yet have a formulation of a sharp necessary and sufficient condition
for ensemble minimaxity of δJ−S in (3.1.1) and δ+J−S in (3.1.2) in the case of general
σ21, · · · , σ2p.
Theorem 3. For any C = c(p− 2) with c > 1, there exists some sufficiently large
p ≥ 3 and some σ21, · · · , σ2p such that δ+J−S in (3.1.2) is not ensemble minimax.
Proof. See Chapter 6.
Figure 3.2 shows a specific example of the relationship between the ensemble
risk of δ+J−S and that of δ0(X) = X. Let p = 1000, σ
2
1 = 10 and σ
2
2 = · · · = σ2p =
0.000001. On the left panel of Figure 3.2, we can find that when C = 0.5(p − 2),
the ensemble risk of δ+J−S is smaller than that of δ0 for any τ
2. On the right panel
of Figure 3.2, however, when C = 1.5(p− 2), δ+J−S does not always dominate δ0.
The above results show that for δ+J−S in (3.1.2) to be ensemble minimax, the
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constant C must have a much smaller upper bound under the general heteroscedastic
model than under the homoscedastic one. Furthermore, it is proved below that δJ−S
in (3.1.1) is not even always ensemble minimax regardless of the choice of C.
Theorem 4. For any C > 0, there exists some σ21,· · · ,σ2p such that δJ−S in (3.1.1)
is not ensemble minimax.
Proof. See Chapter 6.
The fact that δJ−S in (3.1.1) is not in general ensemble minimax may be quite
surprising at first glance. However, this is to be expected given the form of δJ−S.
Under the heteroscedastic model, δJ−S may have a non-negligible probability of dra-
matically over-shrinking, which causes the performance of the shrinkage estimator
to deteriorate; while such an issue is always well controlled in the homoscedastic
case.
Figure 3.3 shows a specific example of the relationship between the ensemble
risk of δJ−S and that of δ0(X) = X. Here we set p = 10, σ21 = 1, σ
2
2 = · · · = σ2p =
0.000001 and C = 5. We find that δJ−S does not always dominate δ0.
Similar to the homoscedastic case, δ+J−S in (3.1.2) is always better than δJ−S in
(3.1.1) in terms of ensemble risk under the heteroscedastic model. A general result
is given in the following theorem.
Theorem 5. Let δ be any estimator with the form δi(X) = (1− hi(X))Xi and δ+
be its positive part estimator such that δ+i (X) = (1−hi(X))+Xi. If P (δ 6= δ+) > 0,
then δ+ dominates δ with respect to P.
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Figure 3.3: Ensemble Risk of δJ−S (Dash Line) and δ0(X) = X (Solid Line)
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Proof. See Chapter 6.
Corollary 4. For any constant C ≥ 0, δ+J−S in (3.1.2) dominates δJ−S in (3.1.1)
with respect to P.
Proof. Directly from Theorem 5.
3.3 Parametric Empirical Bayes Estimators
Carter and Rolph (1974), Brown (2008) and Efron and Morris (1973, 1975) each
derive parametric empirical Bayes estimators for the heteroscedastic problem. The
first two papers use method of moments to estimate the hyperparameter τ 2. (Mor-
ris and Lysy (2009) also discuss such estimators.) We will discuss here ensemble
20
minimaxity of such empirical Bayes estimators.
In contrast, Efron and Morris (1973, 1975) use a maximum likelihood method for
this step. The resulting estimation does not have an explicit closed form, although it
is easily calculated numerically. For this reason we have (so far) been less successful
in settling the ensemble minimaxity of this empirical Bayes version, and we do not
address this issue here.
In this subsection, we treat the special case of shrinkage to 0. The previously
cited references (and others) involve shrinkage to a common mean. This generaliza-
tion is treated in Section 4.2. While our results in the present subsection shed some
light on the ensemble minimaxity of these estimators, they are unfortunately not as
nearly complete as our preceding results about generalized James-Stein estimators.
As mentioned above, if τ 2 is known, the optimal estimator of θi (i = 1, · · · , p)
would be
(δB(X))i =
(
1− σ
2
i
τ 2 + σ2i
)
Xi , (3.3.1)
which is the Bayes estimator. However in the empirical Bayes setting, τ 2 is an
unknown hyperparameter to be estimated. The idea of the parametric empirical
Bayes method is to use {Xi} to obtain an estimate of τ 2 and then substitute the
estimate of τ 2 into (3.3.1) to yield a final estimator of {θi}. Below we use the
method of moments estimator
τ̃ 2 =
1
p
p∑
i=1
(X2i − σ2i ),
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and its positive part
τ̃ 2+ =
1
p
[
p∑
i=1
(X2i − σ2i )
]
+
.
In practice, some other constant “1/C” is oftens used in lieu of “1/p” above.
The corresponding parametric empirical Bayes estimator is then given by
(δPEB(X))i =
(
1− σ
2
i
σ2i +
1
C
∑p
j=1(X
2
j − σ2j )
)
Xi , (3.3.2)
along with its positive part estimator
(δ+PEB(X))i =
(
1− σ
2
i
σ2i +
1
C
(
∑p
j=1(X
2
j − σ2j ))+
)
Xi . (3.3.3)
Note that the form of the parametric empirical Bayes estimator δPEB in (3.3.2)
differs from the James-Stein-type estimator δJ−S in (3.1.1) in the use of the term
Cσ2i +
∑p
j=1(X
2
j −σ2j ) instead of
∑p
j=1 X
2
j in the denominator. Therefore the former
denominator can be much smaller than the latter and hence lead to over-shrinkage.
Not surprisingly, the conditions needed for ensemble minimaxity appear somewhat
more restrictive than in the James-Stein case.
The following corollary contains conditions that guarantee ensemble minimaxity
for the parametric empirical Bayes estimators. Simulation results (not reported
here) lead us to conjecture that ensemble minimaxity holds under somewhat less
restrictive conditions.
Corollary 5. Assume
p ≤
∑p
j=1 σ
2
j
σ2min
≤ C ≤ 2(p− 2) . (3.3.4)
Then both δPEB in (3.3.2) and δ
+
PEB in (3.3.3) are ensemble minimax.
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Remark: In the homoscedastic case, Condition (3.3.4) requires p ≤ 2(p − 2).
This is satisfied if and only if p ≥ 4. In that case, δPEB in (3.3.2) and δ+PEB in
(3.3.3) are ensemble minimax if 4 ≤ p ≤ C ≤ 2(p− 2).
Proof. See Chapter 6.
Theorem 6. Let p ≥ 1 and C > 0. Then there exists some σ21,· · · ,σ2p such that
δPEB in (3.3.2) is not ensemble minimax.
Proof. See Chapter 6.
Unfortunately, we have been unable to obtain a complete answer on the ensem-
ble minimaxity of the positive part estimators δ+PEB in (3.3.3). Nevertheless, the
following theorem indicates that, unlike in the case of James-Stein-type estimators,
C can not be too small.
Theorem 7. For any p, there exists some sufficiently small C and some σ21, · · · , σ2p
such that δ+PEB in (3.3.3) is not ensemble minimax.
Proof. See Chapter 6.
One interesting observation here is that as C → 0, δ+PEB reduces to the hard-
threshold estimator X1{‖X‖2>pσ2} under the homoscedastic model. The above the-
orem simply indicates that the hard-threshold estimator is worse than the ordinary
MLE in terms of ensemble risk when τ 2 > σ2.
Similar to the James-Stein estimator, δ+PEB in (3.3.3) is better than δPEB in
(3.3.2) in terms of ensemble risk.
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Corollary 6. For any constant C ≥ 0, δ+PEB in (3.3.3) dominates δPEB in (3.3.2)
with respect to P.
Proof. Directly from Theorem 5.
Figure 3.4 shows the relationship between the ensemble risk of δ+PEB and that
of δ0(X) = X in various simulations. On the upper left graph, we have p = 5,
Σ = diag{1, 2, 3, 4, 5} and C = 2. On the upper right graph, we have p = 7, Σ =
diag{2.1, 0.5, 1.2, 0.8, 0.3} and C = 1. On the lower left graph, we have p = 10, Σ =
diag{2.9, 1.3, 1.1, 1.6, 2.9, 1.4, 2.5, 2.0, 3.6, 1.3} and C = 9. On the lower right graph,
we have p = 14, Σ = diag{0.9, 1.4, 1.8, 1.0, 1.8, 2.5, 0.3, 2.3, 3.4, 2.9, 0.8, 2.8, 2.2, 0.7}
and C = 20. Although simulation results lend support to the conjecture that δ+PEB
in (3.3.3) is ensemble minimax when 1 ≤ C ≤ 2(p − 2) (the lower bound could be
much smaller) and p ≥ 3, a rigorous proof is still yet to be found.
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Figure 3.4: Ensemble Risk of δ+PEB (Dash Line) and δ0(X) = X (Solid Line)
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Chapter 4
Generalization to Other Cases
4.1 Unknown Variances Case
The discussion so far has been focused on the ensemble minimaxity of shrinkage
estimators assuming the variances σ2i to be known. It is common in many circum-
stances that variances are unknown and have to be estimated from data. Here we
consider the case where Xi ∼ N(θi, σ2γi) for i = 1, · · · , p with unknown σ2 but
known γi. Denote Γ = diag{γ1, · · · , γp}. We also assume that σ2 is estimated by
M ∼ σ2χ2m/m where M is independent of X, an assumption which is satisfied in
applications in which a pooled estimate of σ2 is used. In particular, this setting
corresponds to the one-way random effects setting of Section 4.2 with γi = 1/Ji
where Ji is the number of observations in group i. We will discuss the ensemble
minimaxity of some shrinkage estimators. First of all, we give two lemmas that will
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be used in our later proof. The first one is the generalization of Lemma 1 to the
unknown variances case.
Lemma 2. The ensemble risk of any estimator δ with the form δi(X,M) = (1 −
hi(X, M))Xi has the following representation
Rτ2(δ) =
p∑
i=1
E
[(
σ2γi
τ 2 + σ2γi
Xi − hi(X,M)Xi
)2
+
τ 2σ2γi
τ 2 + σ2γi
]
, (4.1.1)
where the expectation is taken with respect to the joint distribution of (X,M) where
each Xi ∼ N(0, τ 2 + σ2γi) and M ∼ σ2χ2m/m, and they are jointly independent.
Proof. See Chapter 6.
The second lemma is an inequality concerning expectations of non-negative ran-
dom variables.
Lemma 3. For a non-negative random variable M and two non-negative functions
µ(M) and µ′(M), if the ratio r(M) = µ(M)/µ′(M) is non-decreasing in M , we
then have
E(Mµ(M))
E(µ(M))
≥ E(Mµ
′(M))
E(µ′(M))
assuming all expectations are finite and non-zero.
Proof. See Chapter 6.
Define δGSV with the form
(δGSV (X))i =
(
1− λiMγi
νiMγi + ‖X‖2
)
Xi . (4.1.2)
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We have the following theorem characterizing the ensemble minimaxity of δGSV (X)
in (4.1.2). The upper bound for λi is slightly smaller since we are now estimating
σ2i , a phenomenon observed in similar studies under the homoscedastic model.
Theorem 8. δGSV in (4.1.2) is ensemble minimax if p ≥ 3, m ≥ 3 and for any
i = 1, · · · , p, 0 ≤ λi ≤ 2m(p−2)m+2 and νi ≥ ( m+22(m−2)λi − mγmin(p−2)γi(m−2) )+.
Proof. See Chapter 6.
For the corresponding positive part estimator δ+GSV given by
(δ+GSV (X))i =
(
1− λiMγi
νiMγi + ‖X‖2
)
+
Xi , (4.1.3)
as in the case of known variance, a slightly stronger result holds.
Theorem 9. δ+GSV in (4.1.3) is ensemble minimax if p ≥ 3, m ≥ 3 and for any
i = 1, · · · , p, 0 ≤ λi ≤ 2m(p−2)m+2 and νi ≥ (m+2m−2λi − m(p−2)m−2 (1 + γminγi ))+.
Proof. See Chapter 6.
When λi = C and νi = 0, δGSV in (4.1.2) and δ
+
GSV in (4.1.3) reduce to the
James-Stein estimator and its positive part for the unknown variance case. Similar
to the known variances case, the choice of C in the above theorems is different
from that in the homoscedastic case. For the homoscedastic case and ordinary
minimaxity, the upper bound of the constant C can be chosen to be as large as
2m(p−2)
m+2
for the original James-Stein estimators. While for our case, the upper
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bound becomes m(p−2)
m+2
. Like in Theorem 3, it can be shown that the bound can not
be easily improved. However, we omit the result here for simplicity.
We can also extend the parametric Bayes estimator δPEB in (3.3.2) and δ
+
PEB in
(3.3.3) to the unknown variance case. Consider δPEBV with the form
(δPEBV (X))i =
(
1− CMγi
CMγi + (
∑p
j=1 X
2
j −
∑p
j=1 Mγj)
)
Xi (4.1.4)
and δ+PEBV with the form
(δ+PEBV (X))i =
(
1− CMγi
CMγi + (
∑p
j=1 X
2
j −
∑p
j=1 Mγj)+
)
Xi. (4.1.5)
The following corollary gives the conditions that guarantee the ensemble minimaxity
of δPEBV in (4.1.4) and δ
+
PEBV in (4.1.5).
Corollary 7. Assume m ≥ 6, p ≥ 3 and
p ≤
∑p
j=1 γi
γmin
≤ C ≤ 2m(p− 2)
m + 2
. (4.1.6)
Then both δPEBV in (4.1.4) and δ
+
PEBV in (4.1.5) are ensemble minimax.
Proof. See Chapter 6.
4.2 Shrinkage towards the Common Mean
In the sections above, we discuss the ensemble minimaxity properties of the estima-
tors that shrink towards zero under the heteroscedastic model. We will generalize
our method to provide a class of ensemble minimax estimators that shrink towards
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the common mean in this section. Assume that X ∼ N(θ, Σ) and θ ∼ N(µ1, τ 2I),
where Σ is the covariance matrix. We first present a lemma whose proof is suffi-
ciently simple to be omitted.
4.2.1 General Theory
Lemma 4. There exists an orthogonal matrix Q with the form
Q =


1√
p
1T
Q2

 ,
such that T = QΣQT can be written in the block matrix form
T =


T11 T12
T21 T22


where T11 is 1×1, and T22 = diag{t22, · · · , tpp} is a (p−1)×(p−1) diagonal matrix.
From the fact that Q is orthogonal, we have
Q21 = 0
Q2Q
T
2 = Ip−1
QT2 Q2 = Ip −
1
p
11T .
Moreover, we also have T22 = Q2ΣQ
T
2 . Since Σ is positive definite, we can easily
verify that T22 is also positive definite. Therefore, tii > 0 for all i = 2, · · · , p.
Assume p ≥ 4. Let Y = QX ,η = Qθ and Y(2) = (Y2, · · · , Yp)T . Then we have
Y =


1√
p
1T
Q2

 (X1 + (X −X1)) =


√
pX
Q2(X −X1)

 ,
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which implies Y1 =
√
pX and Y(2) = Q2(X−X1). Note that Qµ1 = (√pµ, 0, · · · , 0)T
and Qdiag(τ 2Ip)Q
T = τ 2Ip. Consider the estimator δcm with the form
δcm(X) = Q
T
(
Y1, ξ2(Y(2)), · · · , ξp(Y(2))
)T
, (4.2.1)
where ξi(Y(2)) is any ensemble minimax estimator for η(2), ∀i = 2, · · · , p. We then
have the following result.
Theorem 10. For p ≥ 4, δcm in (4.2.1) is ensemble minimax.
Proof. See Chapter 6.
Note that δcm in (4.2.1) can be interpreted as “shrinking” towards the overall
mean since it can be written as δcm(X) = X1 + Q
T
2 ξ(Q2(X − X1)), which is a
generalized shrinkage estimator.
Furthermore, if we assume that ξi(Y(2)) = (1 − hi(‖Y(2)‖2))Yi for i = 2, · · · , p,
we have
δcm(X) = X1 + Q
T
2 diag{1− h2(‖Y(2)‖2), · · · , 1− hp(‖Y(2)‖2)}Y(2)
= X1 + QT2 diag{1− h2(‖Y(2)‖2), · · · , 1− hp(‖Y(2)‖2)}Q2(X −X1) ,
which, along with the fact that ‖Y(2)‖2 = ‖Q2(X −X1)‖2 = ‖X −X1‖2, implies
δcm(X) = X1 + D · (X −X1)
with D = QT2 diag{1− h2(‖X −X1‖2), · · · , 1− hp(‖X −X1‖2)}Q2.
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4.2.2 Random Effects Models
The standard one-way random effects model involves observations of independent
variables Yij, i = 1, · · · , p, j = 1, · · · , Ji under the distributional assumptions
Yij|θi ∼ N(θi, σ2) (independent)
θi|µ, τ 2 ∼ N(µ, τ 2) (independent) .
Here, the unknown parameters are σ2, µ, τ 2. To fit with previous notation, let
Xi = Yi· =
1
Ji
Ji∑
j=1
Yij
M =
1
n− p
p∑
i
Ji∑
j=1
(Yij − Yi·)2, m =
p∑
i=1
(Ji − 1) = n− p .
Thus, M denotes the usual mean squared errors and m denotes the degrees of
freedom for error.
The goal in random effects estimation (sometimes referred to as “prediction”)
is to estimate (predict) the values of θi under ordinary squared error loss
L(δ, θ) =
p∑
i=1
(δi − θi)2 .
The usual estimator (predictor) is of course δ0(X) = X. This problem is clearly
mathematically equivalent to the ensemble minimaxity formulation. Hence, ensem-
ble minimaxity in the hierarchical formulation is identical to ordinary minimaxity
for the estimation of {θi} in the random effects model.
We construct a class of ensemble minimax generalized shrinkage estimators fol-
lowing the approach in Section 4.2.1. Let Γ = diag{1/J1, · · · , 1/Jp}. From Lemma
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4, there exists an orthogonal matrix Q with the form
Q =


1√
p
1T
Q2

 ,
such that T = QΓQT can be written in the block matrix form
T =


T11 T12
T21 T22


where T11 is 1×1, and T22 = diag{t22, · · · , tpp} is a (p−1)×(p−1) diagonal matrix.
Assume p ≥ 4. Let U = QX ,η = Qθ and U(2) = (U2, · · · , Up)T . Consider the
estimator δcmv with the form
δcmv(X) = Q
T
(
Y1, ξ2(U(2),M), · · · , ξp(U(2),M)
)T
, (4.2.2)
where ξi(U(2),M) is any ensemble minimax estimator for η(2), ∀i = 2, · · · , p. Note
that δcmv in (4.2.2) can be interpreted as “shrinking” towards the overall mean since
it can be written as δcmv(X) = X1 + Q
T
2 ξ(Q2(X −X1),M), which is a generalized
shrinkage estimator. Following the similar approach in Theorem 10, it is easy to
verify that δcmv in (4.2.2) is ensemble minimax.
Especially, if we choose δ+GSV as ξ here, we get the estimator δ
+
GSV ;re with the
form
δ+GSV ;re(X) = X1 + Q
T
2 AQ2(X −X1) , (4.2.3)
where A = diag{(1 − λ2Mt22
ν2Mt22+||X−X1||2 )+, · · · , (1 −
λpMtpp
νpMtpp+||X−X1||2 )+}. We have the
following corollary that shows its ensemble mimimax property.
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Corollary 8. δ+GSV ;re in (4.2.3) is ensemble minimax if p ≥ 4, m ≥ 3 and for any
i = 2, · · · , p, 0 ≤ λi ≤ 2m(p−3)m+2 and νi ≥ (m+2m−2λi− m(p−3)m−2 (1+ tmintii ))+. Hence, δ
+
GSV ;re
is minimax for the random effects model under these conditions and dominates the
usual estimator δ0(X) = X.
In the interest of space we omit the formal proof. If a single version of the above
estimators is to be used for all J1, · · · , Jp, the preferred and simple choice would be
δ+GSV ;re in (4.2.3) with λi =
m(p−3)
m+2
and νi = 0.
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Chapter 5
Further Discussions
In this paper, we propose a class of ensemble minimax estimators that dominate
the usual estimator δ0(X) = X. But there are still many interesting open questions
in this area. Three of them are listed as below.
Q1. How shall we choose the shrinkage factor?
We provide a class of ensemble minimax estimators in our paper, however, we
do not specify how to choose the shrinkage factors among all possibilities. For
example, δ+J−S is ensemble minimax if p ≥ 3 and 0 ≤ C ≤ p − 2. But which C
works best among all possible values? We conjecture that the estimators which have
the largest shrinkage factors are favorable, but we do not have a rigorous proof for
our conjecture. Figure 5.1 provides an example from a simulation study. In this
example, we have p = 6, Σ = diag{0.9, 1.8, 2.3, 2.5, 4.1, 4.6}. The solid line is the
ensemble risk of δ0(X) = X. The circle line, triangle line and cross line are the
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Figure 5.1: Ensemble Risk of δ+J−S with different C and δ0(X) = X
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ensemble risks of δ+J−S with C = 1, C = 2 and C = 3, respectively. As we can
see from Figure 5.1, δ+J−S with C = 3 has the smallest ensemble risk. Theoretical
research of the choice of the shrinkage factor will be an interesting topic for future
work.
Q2. Are these ensemble minimax estimators ensemble admissible?
Another interesting question is to investigate the ensemble admissibility of var-
ious ensemble minimax estimators we propose here. We conjecture that all the
ensemble admissible estimators are either Bayes estimators or limit of Bayes estima-
tors. Therefore, we suspect that the estimators we proposed here are not ensemble
admissible, and some Bayes estimators or limit of Bayes estimators will be a better
candidate. Further research is needed in this area.
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Q3. Can we apply empirical Bayes methods to solve other problem?
In this paper, we use empirical Bayes methods to construct various ensemble
minimax estimators. The key idea is to use the data to extract information for the
underlying structure of the unknown parameters. We can apply this powerful tool
to solve other problems. One possible theoretical application is to solve the Robbins
classification problems under heteroscedastic and unknown variances assumptions
using empirical Bayes methods. It would also be great if we can apply this method
to deal with data from real world.
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Chapter 6
Proofs and Supplemental
Materials
Proof of Lemma 1
Proof. By definition, we have
Rτ2(δ) =
∫ ∫
L(θ, δ(x))Px|θ(dx)πτ (dθ) =
p∑
i=1
E(Xi − θi)2 .
Note that 

θi
Xi

 ∼ N




0
0

 ,


τ 2 τ 2
τ 2 τ 2 + σ2i




and (θi, Xi) are jointly independent for different i, we have from the property of
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conditional expectation
Rτ2(δ) =
p∑
i=1
[Ex(δi(X)− E(θi|X))2 + Ex(E((θi − E(θi|Xi))2|X))]
=
p∑
i=1
[
Ex
(
(1− hi(X))Xi − τ
2
τ 2 + σ2i
Xi
)2
+
τ 2σ2i
τ 2 + σ2i
]
=
p∑
i=1
[
Ex
(
σ2i
τ 2 + σ2i
Xi − hi(X)Xi
)2
+
τ 2σ2i
τ 2 + σ2i
]
where Ex is used to emphasize that the expectation is taken with respect to the
marginal distribution of X, i.e., each coordinate Xi has the normal distribution
N(0, τ 2 + σ2i ) and they are jointly independent.
Proof of Lemma 2
Proof. The proof follows the same approach as in Lemma 1. Once we condition on
M . First note that
Rτ2(δ) = E
[
p∑
i=1
(δi(X, M)− θi)2
]
=
p∑
i=1
E[E[(δi(X,M)− θi)2|M ]]
Since given M , (θi, Xi) is an independent array whose distribution is


θi
Xi

 ∼ N




0
0

 ,


τ 2 τ 2
τ 2 τ 2 + σ2γi



 .
Conditioning on M , we have, as in Lemma 1,
E[(δi(X, M)− θi)2|M ]
= E
[(
σ2γi
τ 2 + σ2γi
Xi − hi(X, M)Xi
)2
|M
]
+
τ 2σ2γi
τ 2 + σ2γi
,
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which then implies
Rτ2(δ) =
p∑
i=1
E[E[(δi(X, M)− θi)2]|M ]
= E
[
p∑
i=1
(
σ2γi
τ 2 + σ2γi
Xi − hi(X,M)Xi
)2
+
τ 2σ2γi
τ 2 + σ2γi
]
.
Proof of Lemma 3
Proof. First we use µ′(M) to induce a new probability distribution
Pµ′(M ∈ A) =
∫
A
µ′(m)
E(µ′(M))
dm .
Using this change of measure, we have
E[Mµ(M)]
E[µ(M)]
= Eµ′ [M · r(M)]× E[µ
′(M)]
E[µ(M)]
and
E(Mµ′(M))
E(µ′(M))
= Eµ′(M) ,
the original inequality then becomes a direct application of covariance inequality
under the new probability Pµ′ .
Proof of Theorem 1
Proof. For any π = N(0, τ 2) ∈ P , the ensemble risk of δ0 with respect to π is given
as
Rτ2(δ0) = Eτ2 [Eθ
p∑
i=1
(Xi − θi)2] =
p∑
i=1
σ2i .
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Moreover, the Bayes risk is
∑p
i=1
σ2i τ
2
σ2i +τ
2 . Therefore, for any estimator δ
′
, we have
Rτ2(δ
′
) ≥
p∑
i=1
σ2i τ
2
σ2i + τ
2
, ∀τ 2 ∈ (0,∞)
Thus,
inf
τ2
sup
δ′
Rτ2(δ
′
) ≥
p∑
i=1
σ2i .
Hence, δ0 is ensemble minimax with respect to P .
Proof of Theorem 2
Proof. From Lemma 1. and the fact that
Rτ2(δ0) =
p∑
i=1
σ2i ,
it suffices to show that for each i,
E
(
σ2i
σ2i + τ
2
Xi − hi(X)Xi
)2
≤ σ
4
i
τ 2 + σ2i
, (6.0.1)
which is equivalent to
E
[
hi(X)
2X2i
] ≤ 2σ
2
i
τ 2 + σ2i
E
[
hi(X)X
2
i
]
.
To prove the above inequality, first note that condition (2) indicates
E
[
hi(X)
2X2i
]
= E
[
hi(T ,W )
2(τ 2 + σ2i )TiW
]
= E
[
E(hi(T ,W )(τ
2 + σ2i )TiW × hi(T ,W )|T )
]
.
From condition (3), (4) and the covariance inequality, we then have
E
[
hi(X)
2X2i
] ≤ E[E(hi(T ,W )(τ 2 + σ2i )TiW |T )× E(hi(T ,W )|T )] ,
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which implies
E
[
hi(X)
2X2i
] ≤ E
[
E(hi(T ,W )(τ
2 + σ2i )TiW |T )× E
(
sup
T
hi(T ,W )|T
)]
.
Based on the independence of T and W , we have
E
[
hi(X)
2X2i
] ≤ E
[
E(hi(T ,W )(τ
2 + σ2i )TiW |T )× E
(
sup
T
hi(T ,W )
)]
= E
(
sup
T
hi(T ,W )
)
× E[hi(T ,W )TiW ] ,
which along from condition (5) shows
E
[
hi(X)
2X2i
] ≤ 2σ
2
i
σ2i + τ
2
E(hi(T ,W )(τ
2 + σ2i )TiW ) =
2σ2i
σ2i + τ
2
E(hi(X)X
2
i ) .
This proves the ensemble minimaxity of δ.
Proof of Theorem 3
Proof. Fix σ21 > 0 and set σ
2
2 = · · · = σ2p = σ2. Let σ2 → 0. In order to show that
δ+J−S dominates δ0 with respect to P , we have to prove
E
[
h1(X)
2X21
] ≤ 2σ
2
1
τ 2 + σ21
E
[
h1(X)X
2
1
]
(6.0.2)
with
h1(X) =
c(p− 2)σ21
‖X‖2 ∧ 1 .
However, the law of large numbers implies that
c(p− 2)σ21
‖X‖2 =
c(p− 2)σ21
p
p
‖X‖2 →
cσ21
τ 2
42
as p →∞. Let σ21 < τ 2 < cσ21, we then have
h1(X) → 1
as p →∞. Since 0 < h1(X) ≤ 1, the dominated convergence theorem implies
E(h1(X)
2X21 ) → τ 2 + σ21
and
E(h1(X)X
2
1 ) → τ 2 + σ21 .
However, our choice of σ21 and τ
2 indicates
1 >
2σ21
τ 2 + σ21
,
which means that the inequality (6.0.2) does not hold for large p. Hence, δ+J−S in
(3.1.2) is not ensemble minimax for some p and σ21, · · · , σ2p.
Proof of Theorem 4
Proof. Fix σ21 = 1, and let σ
2
2 = · · · = σ2p = σ2. It suffices to show
lim
τ2 → 0
σ2 → 0
Rτ2(δJ−S) = ∞ .
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From Lemma 1, we have
lim
τ2 → 0
σ2 → 0
Rτ2(δJ−S) ≥ lim
τ2 → 0
σ2 → 0
E
(
1
τ 2 + 1
X1 − C‖X‖2X1
)2
≥ lim
τ2 → 0
σ2 → 0
1
2
E
(
C
‖X‖2X1
)2
− lim
τ2 → 0
σ2 → 0
E
(
1
τ 2 + 1
X1
)2
≥ lim
τ2 → 0
σ2 → 0
1
2
E
(
C2X21
‖X‖4
)
− 1 .
Since the last term is finite, it is sufficient to prove
lim
τ2 → 0
σ2 → 0
E
(
X21
‖X‖4
)
= ∞ .
Let X1 =
√
1 + τ 2Z1, Z1 ∼ N(0, 1), and Xi =
√
τ 2 + σ2Zi, Zi ∼ N(0, 1), ∀i =
2, · · · , p. Therefore,
E
(
X21
‖X‖4
)
= (1 + τ 2)E
(
Z21
((1 + τ 2)Z21 + (τ
2 + σ2)
∑p
i=2 Z
2
i )
2
)
.
Note that
Z21
((1+τ2)Z21+(τ
2+σ2)
∑p
i=2 Z
2
i )
2 is increasing when both σ
2 and τ 2 decrease to
zero and
lim
τ2 → 0
σ2 → 0
X21
‖X‖4 =
1
Z21
.
From the monotone convergence theorem, we have
lim
τ2 → 0
σ2 → 0
E
(
X21
‖X‖4
)
= E
(
1
Z21
)
= ∞
which completes the proof.
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Proof of Theorem 5
Proof. First note that δ+i is equivalently written as δ
+
i (X) = (1− h+i (X))X, where
h+i (X) = hi(x) ∧ 1. From Lemma 1, we have
Rτ2(δ
+)−Rτ2(δ)
=
p∑
i=1
E
[(
h+i (X) + hi(X)−
2σ2i
τ 2 + σ2i
)
(hi(X)− h+i (X))X2i
]
.
Since for any i = 1, · · · , p,
hi(X)− h+i (X) =



hi(X)− 1 , if hi(X) > 1
0 , if hi(X) ≤ 1
,
we then have
Rτ2(δ
+)−Rτ2(δ)
=
p∑
i=1
E
[(
h+i (X) + hi(X)−
2σ2i
τ 2 + σ2i
)
(hi(X)− h+i (X))X2i
]
=
p∑
i=1
E
[(
1 + hi(X)− 2σ
2
i
τ 2 + σ2i
)
(hi(X)− 1)X2i I{hi(X)>1}
]
≥
p∑
i=1
E
[(
2− 2σ
2
i
τ 2 + σ2i
)
(hi(X)− 1)X2i I{hi(X)>1}
]
> 0
which completes the proof.
Proof of Theorem 6
Proof. When p = 1, set τ 2 = 1. From Lemma 1, we only need to show
lim
σ21→0
E
(
1
1 + σ21
X1 − C
X21 + (C − 1)σ21
X1
)2
>
1
1 + σ21
.
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Since
E
(
1
1 + σ21
X1 − C
X21 + (C − 1)σ21
X1
)2
≥ 1
2
E
(
C
X21 + (C − 1)σ21
X1
)2
− E
(
1
1 + σ21
X1
)2
=
1
2
E
(
C2X21
(X21 + (C − 1)σ21)2
)
− 1
1 + σ21
where the last term is finite, it is then sufficient to show
lim
σ21→0
E
(
X21
(X21 + (C − 1)σ21)2
)
= ∞ . (6.0.3)
When C < 1, this is trivial. In fact, it holds for any σ21. When C ≥ 1, let
X1 =
√
1 + σ21Z1, Z1 ∼ N(0, 1), we have
E
(
X21
(X21 + (C − 1)σ21)2
)
= E
(
(1 + σ21)Z
2
1
((1 + σ21)Z
2
1 + (C − 1)σ21)2
)
.
Since
Z21
((1+σ21)Z
2
1+(C−1)σ21)2
is increasing as σ21 → 0, and
lim
σ21→0
Z21
((1 + σ21)Z
2
1 + (C − 1)σ21)2
=
1
Z21
,
from monotone convergence theorem, we have
lim
σ21→0
E
(
Z21
((1 + σ21)Z
2
1 + (C − 1)σ21)2
)
= E
(
1
Z21
)
= ∞ .
Note that 1 + σ21 → 1 as σ21 → 0, (6.0.3) is then verified. Hence, when p = 1, δPEB
in (3.3.2) is not ensemble minimax.
For the case where p ≥ 2, let σ21 = 1 and σ22 = · · · = σ2p = C. Again from
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Lemma 1, we have
Rτ2(δPEB) ≥ E
(
1
τ 2 + 1
x1 − C
C + ‖X‖2 − 1− (p− 1)C X1
)2
≥ 1
2
E
(
C2X21
(‖X‖2 − 1− (p− 2)C)2
)
− E
(
1
(τ 2 + 1)2
X21
)
=
1
2
E
(
C2X21
(‖X‖2 − 1− (p− 2)C)2
)
− 1
τ 2 + 1
=
1
2
E
[
E
(
C2X21
(‖X‖2 − 1− (p− 2)C)2 | X1
)]
− 1
τ 2 + 1
.
For any X21 < 1 + (p− 2)C, it is not difficult to see that
E
(
C2X21
(‖X‖2 − 1− (p− 2)C)2 | X1
)
= ∞
and
P (X21 < 1 + (p− 2)C) > 0 ,
we then have
E
(
C2X21
(‖X‖2 − 1− (p− 2)C)2
)
= ∞ ,
which implies
Rτ2(δPEB) = ∞ . (6.0.4)
Therefore, δPEB in (3.3.2) is not ensemble minimax. To sum up, there exists some
σ21, · · · , σ2p such that δPEB in (3.3.2) is not ensemble minimax.
Proof of Theorem 7
Proof. Let σ21 = · · · = σ2p = 1 and τ 2 = 2. Similarly as above, to show that δ+PEB in
(3.3.3) is ensemble minimax, we would need to have
E
(
p∑
i=1
h2i (X)X
2
i
)
≤ 2
3
E
(
p∑
i=1
hi(X)X
2
i
)
(6.0.5)
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with
hi(X) =
1
1 + 1
C
(‖X‖2 − p)+
.
Notice that hi(X) → I{‖X‖2≤p} as C → 0 and hi(X) ≤ 1, from dominant convergence
theorem, we have
E
(
p∑
i=1
h2i (X)X
2
i
)
→ E [‖X‖2I{‖X‖2≤p}
]
and
E
(
p∑
i=1
hi(X)X
2
i
)
→ E [‖X‖2I{‖X‖2≤p}
]
as C → 0. Hence, as C → 0, (6.0.5) would no longer always hold. Thus, there
exists some sufficiently small C and some σ21, · · · , σ2p such that δ+PEB in (3.3.3) is
not ensemble minimax.
Proof of Theorem 8
Proof. As in the proof for the known variance case, based on Lemma 2, it suffices
to show
E
[(
λiMγi
νiMγi + ‖X‖2
)2
X2i
]
≤ 2σ
2γi
σ2γi + τ 2
E
(
λiMγi
νiMγi + ‖X‖2X
2
i
)
.
Conditioning on M and following the proof in Theorem 2 and Corollary 2, we know
E
[(
λiMγi
νiMγi + ‖X‖2
)2
X2i
]
≤ E
[
E
(
λiMγi
νiMγi + ‖X‖2X
2
i |M
)
× E
(
λiMγi
νiMγi + (σ2γmin + τ 2)W
|M
)]
.
The difficulty here is that a direct application of the covariance inequality on the
two conditional expectation is no longer helpful since they are both increasing in M .
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However, by moving the M in the numerator of the second conditional expectation
to the first one, the covariance inequality can then be applied, i.e.,
E
[(
λiMγi
νiMγi + ‖X‖2
)2
X2i
]
≤ E
[
E
(
λiMγi
νiMγi + ‖X‖2X
2
i |M
)
× E
(
λiMγi
νiMγi + (σ2γmin + τ 2)W
|M
)]
= E
[
E
(
λiM
2γi
νiMγi + ‖X‖2X
2
i |M
)
× E
(
λiγi
νiMγi + (σ2γmin + τ 2)W
|M
)]
= E
[
E
(
λiM
2γi
νiMγi + ‖X‖2X
2
i |M
)]
× E
[
E
(
λiγi
νiMγi + (σ2γmin + τ 2)W
|M
)]
= E
(
λiM
2γi
νiMγi + ‖X‖2X
2
i
)
× E
(
λiγi
νiMγi + (σ2γmin + τ 2)W
)
.
Now let
µs(M) =
λiMγi
νiMγi + s
,
notice that the ratio r(M) = µs(M)/µs′(M) is non-decreasing in M for s > s
′, from
Lemma 3, we then have
E
(
λiM
2γi
νiMγi+‖X‖2 |X
)
E
(
λiMγi
νiMγi+‖X‖2 |X
) ≤ lim
‖X‖2→∞
E
(
λiM
2γi
νiMγi+‖X‖2 |X
)
E
(
λiMγi
νiMγi+‖X‖2 |X
) = lim
‖X‖2→∞
E
(
λiM
2γi·‖X‖2
νiMγi+‖X‖2 |X
)
E
(
λiMγi·‖X‖2
νiMγi+‖X‖2 |X
) .
Applying monotone convergence theorem gives us
lim
‖X‖2→∞
E
(
λiM
2γi·‖X‖2
νiMγi+‖X‖2 |X
)
E
(
λiMγi·‖X‖2
νiMγi+‖X‖2 |X
) = E(M
2)
E(M)
=
(m + 2)σ2
m
,
which along with the previous inequality implies
E
(
λiM
2γi
νiMγi + ‖X‖2 |X
)
≤ (m + 2)σ
2
m
E
(
λiMγi
νiMγi + ‖X‖2 |X
)
.
Multiplying both sides by X2i and taking expectation leads to
E
(
λiM
2γi
νiMγi + ‖X‖2X
2
i
)
≤ (m + 2)σ
2
m
E
(
λiMγi
νiMγi + ‖X‖2X
2
i
)
.
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Since we have already shown that
E
[(
λiMγi
νiMγi + τ 2W
)2
X2i
]
≤ E
(
λiM
2γi
νiMγi + ‖X‖2X
2
i
)
× E
(
λiγi
νiMγi + (σ2γmin + τ 2)W
)
,
in order to prove
E
[(
λiMγi
νiMγi + ‖X‖2
)2
X2i
]
≤ 2σ
2γi
σ2γi + τ 2
E
(
λiMγi
νiMγi + ‖X‖2X
2
i
)
,
it is then sufficient to show
(m + 2)σ2
m
E
(
λiγi
νiMγi + (σ2γmin + τ 2)W
)
≤ 2σ
2γi
σ2γi + τ 2
.
As in the proof of Corollary 2, using the covariance inequality twice, we have
(m + 2)σ2
m
E
(
λiγi
νiMγi + (σ2γmin + τ 2)W
)
=
(m + 2)σ2
m
E
[
E
(
λiγi/W
νiMγi/W + (σ2γmin + τ 2)
)
|M
]
=
(m + 2)σ2
m
E
[
E(λiγi/W |M)
E[(νiMγi/W + (σ2γmin + τ 2))|M ]
]
=
(m + 2)σ2
m
E
[
λiγi
νiMγi + (p− 2)(σ2γmin + τ 2)
]
=
(m + 2)σ2
m
E
[
λiγi/M
νiγi + (p− 2)(σ2γmin + τ 2)/M
]
≤ (m + 2)σ
2
m
E(λiγi/M)
E(νiγi + (p− 2)(σ2γmin + τ 2)/M)
=
(m + 2)σ2
m
λiγi ·m/(m− 2)
νiσ2γi + (p− 2)(σ2γmin + τ 2) ·m/(m− 2)
=
(m + 2)λiγi · σ2
(m− 2)νiσ2γi + m(p− 2)(σ2γmin + τ 2) .
Now applying the condition 0 ≤ λi ≤ 2m(p−2)m+2 and νi ≥ ( m+22(m−2)λi− mγmin(p−2)γi(m−2) )+, we
finally have
(m + 2)λiγi · σ2
(m− 2)νiσ2γi + m(p− 2)(σ2γmin + τ 2) ≤
2σ2γi
σ2γi + τ 2
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which completes the proof.
Proof of Theorem 9
Proof. The proof follows similar steps in the proofs of Corollary 3 and Theorem
8, therefore, we will skip most of the details and only highlight the parts that are
substantially different. First let the shrinkage factor
h+i (X, M) = min(1, hi(X, M)) = min
(
1,
λiMγi
νiMγi + ‖X‖2
)
.
As before, we have to prove
E
[
h+i (X,M)
2X2i
] ≤ 2σ
2γi
σ2γi + τ 2
E
[
h+i (X, M)X
2
i
]
.
When σ2γi ≥ τ 2, the above inequality is trivial. From now on, assume σ2γi < τ 2.
As in the proof of Theorem 8, we have
E
[
h+i (X,M)
2X2i
] ≤ E (h+i (X, M)MX2i
)× E
(
λiγi
νiMγi + (σ2γmin + τ 2)W
)
.
Define
µs(M) = min
(
1,
λiMγi
νiMγi + s
)
.
Note that the ratio r(M) = µs(M)/µ
′
s(M) is still non-decreasing in M for s > s
′.
As in Theorem 8, applying Lemma 3 and monotone convergence theorem leads to
E
(
h+i (X, M)MX
2
i
) ≤ (m + 2)σ
2
m
E
(
h+i (X, M)X
2
i
)
.
It is then sufficient to show
(m + 2)σ2
m
E
(
λiγi
νiMγi + (σ2γmin + τ 2)W
)
≤ 2σ
2γi
σ2γi + τ 2
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whose proof follows exactly the same argument used in the last part of the proof of
Corollary 3.
Proof of Theorem 10
Proof. Since ξ(Y(2)) is an ensemble minimax estimator for η(2), we have that
E
[
p∑
i=2
(
ξi(Y(2))− ηi
)2
]
≤ trace(T22) ,
which along with
E[(Y1 − η1)2] = T11
and trace(T ) = trace(Σ) implies
E
[
(Y1 − η1)2 +
p∑
i=2
(
ξi(Y(2))− ηi
)2
]
≤ trace(Σ) .
Therefore, we have
E
[
p∑
i=1
((δc(X))i − θi)2
]
= E
[
(QT (Y1 − η1, ξ2(Y(2))− η2, · · · , ξp(Y(2))− ηp)T )T
· (QT (Y1 − η1, ξ2(Y(2))− η2, · · · , ξp(Y(2))− ηp)T )
]
= E
[
(Y1 − η1)2 +
p∑
i=2
(
ξi(Y(2))− ηi
)2
]
≤ trace(Σ)
which completes the proof.
Proof of Corollary 2
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Proof. It is sufficient for us to verify that the conditions in Theorem 2 are satisfied
by
hi(X) =
λiσ
2
i
νiσ2i + ‖X‖2
=
λiσ
2
i
νiσ2i +
∑p
j=1(σ
2
i + τ
2)TiW
= hi(T ,W ) .
Clearly, the shrinkage factor hi(X) satisfies conditions (1)-(4). For (5), define gi(W )
as
gi(W ) =
λiσ
2
i
νiσ2i + (σ
2
min + τ
2)W
.
Then, supT hi(T ,W ) ≤ gi(W ). Using the covariance inequality, we have
E[gi(W )] = E
[
λiσ
2
i /W
νiσ2i /W + σ
2
min + τ
2
]
≤ E[λiσ
2
i /W ]
E[νiσ2i /W + σ
2
min + τ
2]
=
λiσ
2
i
νiσ2i + (p− 2)(σ2min + τ 2)
.
From the condition 0 ≤ λi ≤ 2(p − 2) and νi ≥ (λi/2 − (p − 2) · σ2min/σ2i )+ , it is
then easy to verify
λiσ
2
i
νiσ2i + (p− 2)(σ2min + τ 2)
≤ 2σ
2
i
σ2i + τ
2
,
which completes the proof.
Proof of Corollary 3
Proof. As in the proof of Corollary 2, it is sufficient for us to verify that conditions
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in Theorem 2 are satisfied by h+i (X) = hi(X) ∧ 1, where
hi(X) =
λiσ
2
i
νiσ2i + ‖X‖2
=
λiσ
2
i
νiσ2i +
∑p
j=1(σ
2
i + τ
2)TiW
= hi(T ,W ) .
Conditions (1)-(4) are straightforward. If τ 2 ≤ σ2i , (5) is also automatically satisfied.
Assuming τ 2 > σ2i , define gi(W ) as
gi(W ) =
λiσ
2
i
νiσ2i + (σ
2
min + τ
2)W
.
Note that supT hi(T ,W ) ≤ gi(W ). Using the covariance inequality we have
E[gi(W )] = E
[
λiσ
2
i /W
νiσ2i /W + σ
2
min + τ
2
]
≤ E[λiσ
2
i /W ]
E[νiσ2i /W + σ
2
min + τ
2]
=
λiσ
2
i
νiσ2i + (p− 2)(σ2min + τ 2)
.
Now we only need to show
λiσ
2
i
νiσ2i + (p− 2)(σ2min + τ 2)
≤ 2σ
2
i
σ2i + τ
2
for τ 2 > σ2i , which is equivalent to
2σ2i ((p− 2)− νi) ≤ (σ2i + τ 2)(2(p− 2)− λi) + 2(p− 2)σ2min .
Since 0 ≤ λi ≤ 2(p− 2) and νi ≥ [λi − (p− 2)(1 + σ2min/σ2)]+, we have
2σ2i ((p− 2)− νi) ≤ 2σ2i (2(p− 2)− λi) + 2(p− 2)σ2min
≤ (σ2i + τ 2)(2(p− 2)− λi) + 2(p− 2)σ2min ,
which completes the proof.
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Proof of Corollary 5
Proof. Set λi = C and νi = C −
∑p
j=1 σ
2
j
σ2i
. Condition (3.3.4) guarantees that νi ≥ 0
and λi ≤ 2(p − 2). It is evident that δPEB = δGS. A little care with the positive
part conditions shows that also δ+PEB = δ
+
GS.
It then follows from Corollary 2 that δPEB = δGS is ensemble minimax if
diff = νi − [C
2
− (p− 2)σ
2
min
σ2i
] ≥ 0. (6.0.6)
Substituting and simplifying yields
diff =
C
2
− [
∑p
j=1 σ
2
j
σ2i
− (p− 2)σ
2
min
σ2i
]
≥ C
2
−
∑p
j=1 σ
2
j − (p− 2)σ2min
σ2min
,
since
∑p
j=1 σ
2
j ≥ pσ2min ≥ (p− 2)σ2min. Hence, from (3.3.4),
diff ≥ C
2
+ p− 2−
∑p
j=1 σ
2
j
σ2min
≥ 1
2
[C −
∑p
j=1 σ
2
j
σ2min
]
≥ 0 .
This verifies (6.0.6) and proves δPEB is ensemble minimax.
The proof for δ+PEB is similar, but easier. λi and νi are defined as before. Con-
dition (3.3.4) is still required in order that 0 ≤ λi ≤ 2(p− 2) and νi ≥ 0. Truth of
(6.0.6) validates the remaining condition in Corollary 3, and hence proves δ+PEB is
ensemble minimax.
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Proof of Corollary 7
Proof. Set λi = C and νi = C −
∑p
j=1 γi
γmin
. Condition (4.1.6) guarantees that νi ≥ 0
and λi ≤ 2m(p−2)m+2 . It is evident that δPEBV = δGSV . A little care with the positive
part conditions shows that also δ+PEBV = δ
+
GSV .
It then follows from Theorem 8 that δPEBV = δGSV is ensemble minimax if
diff = νi − [ m + 2
2(m− 2)C −
m(p− 2)γmin
(m− 2)γi ] ≥ 0. (6.0.7)
Substituting and simplifying yields
diff =
m− 6
2(m− 2)C +
m(p− 2)γmin
(m− 2)γi −
∑p
j=1 γj
γi
≥ m− 6
2(m− 2)
∑p
j=1 γj
γi
+
m(p− 2)γmin
(m− 2)γi −
∑p
j=1 γj
γi
=
γmin
γi
[
m(p− 2)
m− 2 −
m + 2
2(m− 2)
∑p
j=1 γj
γmin
]
≥ γmin
γi
[
m(p− 2)
m− 2 −
m + 2
2(m− 2)
2m(p− 2)
m + 2
]
= 0 .
This verifies (6.0.7) and proves δPEBV is ensemble minimax.
The proof for δ+PEBV is similar, but easier. λi and νi are defined as before.
Condition (4.1.6) is still required in order that 0 ≤ λi ≤ 2m(p−2)m+2 and νi ≥ 0. Truth
of (6.0.7) validates the remaining condition in Theorem 9, and hence proves δ+PEBV
is ensemble minimax.
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Part II: Application In Causal Inference
Inference for the Effect of Treatment on
Survival Probability in Randomized Trials
with Noncompliance and Administrative
Censoring
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Chapter 7
Introduction and Background
Knowledge
In randomized trials with a survival outcome, two common problems are admin-
istrative censoring and noncompliance. Administrative censoring means follow-up
ends at a pre-specified date when many subjects have not failed yet. Noncompliance
means a subject does not take his or her assigned treatment. A trial that had both
administrative censoring and noncompliance is the HIP study, a randomized trial
of breast cancer screening (Joffe, 2001). Other examples of trials involving both ad-
ministrative censoring and noncompliance are Kubik (1990), Follmann (2000) and
Oken (2005). When there is noncompliance, in addition to the intent-to-treat effect,
it is often of interest to estimate the causal effect of actually receiving the active
treatment compared to receiving the control. Knowledge of this effect is useful for
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predicting the impact of the treatment in a setting for which compliance patterns
might differ from the randomized trial and for scientific understanding of the treat-
ment (Sommer and Zeger, 1991; Sheiner and Rubin, 1995; Cheng and Small, 2006;
Small et al., 2006).
There is a lot of literature studying the causal effect of a treatment on a contin-
uous, binary or multinomial outcome when there is noncompliance. A few papers
have considered trials with a survival time as the outcome in the presence of non-
compliance. Robins and Tsiatis (1991) consider a structural accelerated failure
time model in which treatment multiplies the failure time by a constant factor for
each subject, and developed semiparametric estimators for this model. Joffe (2001)
provides a good discussion of their approach and comparisons with other survival
analysis methods. Loeys and Goetghebeur (2003) and Cuzick et al. (2007) consider
a structural proportional hazards model in which the hazard of the potential failure
time under treatment for a certain group of subjects is proportional to the hazard
of the potential failure time under control for these same subjects. Both the struc-
tural accelerated failure time model and the structural proportional hazards model
are semiparametric models, the parametric part being the effect of the treatment
on the distribution of failure times. In this paper we use empirical likelihood (a
nonparametric approach) to estimate the effect of treatment on survival at specific
times in the presence of non-compliance and administrative censoring. Our work
builds on Baker (1998). Baker extends the model and assumptions for settings with
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noncompliance of Baker and Lindeman (1994) and Angrist et al. (1996) to discrete-
time survival data. He derives closed form expressions for the maximum likelihood
estimates of the hazards of compliers (subjects who would only receive the treat-
ment if assigned to the treatment) in the treatment and control groups when these
estimates lie in the interior of the parameter space. For the effect of the treatment
at a specific time, Baker’s estimator is analogous to the standard instrumental vari-
able (IV) estimator in the setting with a survival outcome. However, this estimator
can provide negative estimates of hazards (Baker, 1998) and be inefficient in some
situations. The reason for the inefficiency is the same as the reason that the stan-
dard IV estimator is inefficient in the non-survival setting: standard IV methods do
not fully use the mixture structure implied by the latent compliance model (Imbens
and Rubin, 1997; Cheng et al., 2009a; Cheng et al., 2009b). The nonparametric
approach developed in this paper makes full use of this mixture structure and thus
has the potential to be more efficient than the standard IV method.
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Chapter 8
Model Framework
8.1 Notation
We assume that the treatment has two levels. Let R be the indicator vector of
randomization assignments for all subjects. Its individual element Ri = ri ∈ {0, 1}
indicates the randomization assignment for subject i: Ri = 1 if subject i is assigned
active treatment (hereafter, it is referred to as ’treatment’), Ri = 0 for control. We
also let Ar denote the vector of potential treatments received under randomization
assignments r. Its individual element Ari = ai ∈ {0, 1}, is equal to 1 if subject i
takes the treatment and 0 if subject i takes the control under the randomization
assignments r.
Let T r,a be the vector of the potential failure times under randomization as-
signments r and treatments received a. Its individual element T r,ai is the potential
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failure time for subject i with the vector of randomization assignments r and the
vector of treatment received a. Let C denote the vector of administrative censoring
times for all subjects with individual element Ci as the administrative censoring
time for subject i, i.e., Ci is the time between the date of enrollment for subject
i and the prespecified date at which follow-up finishes. Subject i would get cen-
sored under randomization assignments r and treatments received a if T r,ai > Ci.
Let Y r,ai = min{T r,ai , Ci} denote the length of subject i’s follow-up time and let
∆r,ai = I{T r,ai ≤ Ci} be an indicator of failure for subject i under r, a; ∆r,ai = 1 if
failure occurs before censoring and ∆r,ai = 0 otherwise.
8.2 Assumptions
We make the same five assumptions as Angrist, Imbens and Rubin (1996) made for
the non-survival setting and then an additional assumption for the survival setting.
Assumption 1: Stable Unit Treatment Value Assumption (SUTVA)
(Rubin, 1978).
a. If ri = r
′
i, then A
r
i = A
r
′
i for all i.
b. If ri = r
′
i and ai = a
′
i, then T
r,a
i = T
r
′
,a
′
i for all i.
The SUVTA assumption allows us to write T r,ai , Y
r,a
i , ∆
r,a
i and A
r
i as T
ri,ai
i ,
Y ri,aii , ∆
ri,ai
i and A
ri,ai
i respectively for subject i.
Assumption 2: Random Assignment
The treatment assignment Ri is random: Pr(R = u) = Pr(R = u
′
) for all u
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and u
′
such that lT u = lT u
′
, where l is the vector with all elements equal to one.
Assumption 3: Exclusion Restriction
T ri,aii = T
r
′
i ,ai
i for all ri, r
′
i, ai and all subjects i.
According to this assumption, the randomization assignment does not affect the
potential failure time except through its effect on the treatment received. Thus, we
write T ri,aii , Y
ri,ai
i and ∆
ri,ai
i as T
ai
i , Y
ai
i and ∆
ai
i respectively for subject i.
Assumption 4: Nonzero Average Causal Effect of R on A
E(A1i − A0i ) 6= 0.
This assumption requires randomization assignment R to have an effect on the
average probability of receiving treatment.
Assumption 5: Monotonicity (Imbens and Angrist, 1994).
A1i ≥ A0i for all i, which rules out treatment defiers.
Besides Assumptions 1 - 5 from Angrist et al. (1996), we also make the following
assumption as in Kaplan and Meier (1958).
Assumption 6: Independence of Failure Times and Censoring Times
The distributions of potential failure times T and administrative censoring times
C are independent of each other. Type I censoring (i.e., censoring times are the
same for all subjects) and random censoring are two special cases.
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8.3 Compliance Classes
A subject in a two-arm trial can be classified into one of four compliance classes:
always-takers (A1 = 1, A0 = 1), who will always take the treatment no matter which
group they are assigned to; compliers (A1 = 1, A0 = 0), who will comply with their
assignments; never-takers (A1 = 0, A0 = 0), who will never take the treatment no
matter which group they are assigned to; and defiers (A1 = 0, A0 = 1), who will do
the opposite of their assigned treatment. Note the monotonicity assumption rules
out the existence of defiers. First assume
Assumption 7: Only Compliers and Never-takers in Our Model
This occurs in a trial in which only subjects assigned to the treatment have the
opportunity to receive the treatment, e.g., a single consent design (Zelen, 1979).
Let I = 1 if the subject is a complier and I = 0 if he or she is a never-taker.
Let πc = P (I = 1). We will later extend our results to more general trials with
always-takers.
8.4 Model Structure
Under Assumption 7, the compliance status is observed for the treatment group
but not for the control group. If R = 1 and A = 1, we know that the subject is a
complier; if R = 1 and A = 0, we know that the subject is a never-taker. However,
in the control group, we cannot tell which group the subject belongs to, and hence
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have a mixture of compliers and never-takers in the control arm. We can organize
the data as follows, where there are m1 + m2 subjects in the treatment group and
N subjects in the control group:
1. Compliers in the Treatment Group
For i = 1, · · · ,m1, assume that Ri = 1 and Ai = 1, which means that they are
compliers in the treatment group (Ii = 1). Let Yi denote the observed follow-
up time for subject i and ∆i denote the censoring indicator. Let the n1 ordered
unique failure times corresponding to {Yi}m1i=1 be 0 < T (1)1 < · · · < T (1)n1 < ∞,
where n1 ≤ m1. For j = 1, · · · , n1, let d(1)j be the number of failures at T (1)j
and r
(1)
j be the number of subjects at risk of failure just prior to T
(1)
j .
2. Never-takers in the Treatment Group
For i = m1 + 1, · · · ,m1 + m2, assume that Ri = 1 and Ai = 0, which means
that they are never-takers in the treatment group (Ii = 0). Again, let Yi
denote the observed follow-up time for subject i and ∆i denote the censoring
indicator. Let the n2 ordered unique failure times corresponding to {Yi}m1+m2i=m1+1
be 0 < T
(2)
1 < · · · < T (2)n2 < ∞, where n2 ≤ m2. For j = 1, · · · , n2, let d(2)j
be the number of failures at T
(2)
j and r
(2)
j be the number of subjects at risk of
failure just prior to T
(2)
j .
3. Mixture in the Control Group
For i = m1 +m2 +1, · · · ,m1 +m2 +N , assume that Ri = 0, which shows that
they are subjects in the control group. Similarly, let the n3 ordered unique
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failure times corresponding to {Yi}m1+m2+Ni=m1+m2+1 be 0 < T
(3)
1 < · · · < T (3)n3 < ∞,
where n3 ≤ N .
We assume that the survival functions of compliers in the treatment group and
compliers in the control group at time V are given by Sc1(V ) and Sc0(V ) respectively.
Never-takers in both the treatment group and control group have the same survival
function Snt(V ) at time V because of the exclusion restriction (Assumption 3).
Furthermore, we let ST |R=1(V ) and ST |R=0(V ) denote the survival probabilities at
time point V of the mixture distribution in the treatment group and that in the
control group, respectively. Notice that
ST |R=1(V ) = πcSc1(V ) + (1− πc)Snt(V )
ST |R=0(V ) = πcSc0(V ) + (1− πc)Snt(V )
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Chapter 9
Main Results
9.1 Standard Instrumental Variable Estimation
Under Assumptions 1 - 6, the compliers are the only subgroup for which a random-
ized trial provides information on the causal effect of receiving treatment (Angrist
et al., 1996). By Proposition 1 in Angrist et al. (1996), the difference between the
survival probability at a time point V of compliers in the treatment group and that
in the control group is given by
W (V ) =
ST |R=1(V )− ST |R=0(V )
E[A|R = 1]− E[A|R = 0]
which is the difference of the survival probability at time V in the two arms divided
by the proportion of compliers. Under Assumption 7, note that E[A|R = 0] = 0
since there are no subjects with treatment in the control group. The standard IV
estimator is given by substituting estimators of the quantities in the above formula,
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i.e.,
Ŵ (V ) =
ŜT |R=1(V )− ŜT |R=0(V )
Ê[A|R = 1]− Ê[A|R = 0] (9.1.1)
where Ê denotes the sample mean, and ŜT |R=1(V ), ŜT |R=0(V ) represent the Kaplan-
Meier estimators in the treatment arm and the control arm, respectively. In the
survival setting, Assumption 6 is needed to ensure that these Kaplan-Meier esti-
mators are consistent. (9.1.1) is also the standard IV estimator for general trials
under Assumptions 1 - 6, where always-takers exist in both arms. The estimators
in Baker (1998) are equivalent to the standard IV estimators. For the standard IV
method in the non-survival setting, Angrist et al. (1996) provides the foundation
and Cheng et al. (2009b) discusses various properties.
Although the standard IV estimator is very useful, it does not take full advan-
tages of the mixture structure of the outcomes in two arms. The likelihood approach
which uses the mixture information provides considerable efficiency gains over the
standard IV estimation.
9.2 Parametric Maximum Likelihood Estimation
The maximum likelihood approach is a powerful tool under a parametric model.
We use the EM-algorithm to find the maximum likelihood estimators of the param-
eters in our model, and then get the maximum likelihood estimator of the difference
between the survival probability of the compliers in the treatment group and the
survival probability of the compliers in the control group at a specific time V .
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We illustrate this method through an example with assumptions of Weibull distri-
butions. However, our method can be easily applied under assumptions of other
distributions.
Example
Assume that the compliers in the treatment group, the compliers in the control
group and the never-takers have Weibull distributions with parameters ρc1, κc1, ρc0,
κc0 and ρnt, κnt, respectively. The likelihood function can be written as:
Lobs =
m1∏
i=1
πcL
c1
i
m1+m2∏
i=m1+1
(1− πc)Lnti
m1+m2+N∏
i=m1+m2+1
(πcL
c0
i + (1− πc)Lnti )
where
Lc1i = (κc1ρc1(ρc1Yi)
κc1−1)∆i exp (−(ρc1Yi)κc1), i = 1, · · · ,m1
Lc0i = (κc0ρc0(ρc0Yi)
κc0−1)∆i exp (−(ρc0Yi)κc0), i = m1 + m2 + 1, · · · ,m1 + m2 + N
Lnti = (κntρnt(ρntYi)
κnt−1)∆i exp (−(ρntYi)κnt), i = m1 + 1, · · · ,m1 + m2 + N
Viewing the compliance class as missing data, the complete data likelihood func-
tion is
Lc =
m1∏
i=1
πcL
c1
i
m1+m2∏
i=m1+1
(1− πc)Lnti
m1+m2+N∏
i=m1+m2+1
(πcL
c0
i )
Ii((1− πc)Lnti )1−Ii (9.2.1)
We directly find the MLEs for ρc1 and κc1 by solving the two equations below
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∑m1
i=1 ∆i
κc1
+
m1∑
i=1
∆i log Yi =
∑m1
i=1 ∆i
∑m1
i=1 Y
κc1
i log Yi∑m1
i=1 Y
κc1
i
ρc1 = (
∑m1
i=1 ∆i∑m1
i=1 Y
κc1
i
)
1
κc1
For the other parameters, we use the EM-algorithm to find their MLEs.
E-step Let Îi denote E(Ii|θ̂(t)), where θ̂(t) is the vector of estimates of πc, ρc0,
κc0, ρnt and κnt at the tth iteration of the EM-algorithm. For i = m1 + m2 +
1, · · · ,m1 + m2 + N , we have
Îi =
πcL
c0
i
πcLc0i + (1− πc)Lnti
(9.2.2)
where Lc0i , L
nt
i and πc are evaluated at θ̂
(t). For i = m1 + 1, · · · ,m1 + m2, Îi = 0.
Because the complete data log-likelihood function is linear in Ii, the expected value
of the complete data log-likelihood given θ̂(t) is obtained by substituting Îi into
(9.2.1).
M-Step After substituting (9.2.2) into (9.2.1), we get the maximizers of πc, ρc0,
κc0, ρnt and κnt by setting the first derivatives as zero and solving five equations
below.
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πc =
m1 +
∑m1+m2+N
i=m1+m2+1
Îi
m1 + m2 + N
ρc0 = (
∑m1+m2+N
i=m1+m2+1
Îi∆i∑m1+m2+N
i=m1+m2+1
ÎiY
κc0
i
)
1
κc0
ρnt = (
∑m1+m2+N
i=m1+1
(1− Îi)∆i∑m1+m2+N
i=m1+1
(1− Îi)Y κnti
)
1
κnt
∑m1+m2+N
i=m1+m2+1
∆iÎi
κc0
+
m1+m2+N∑
i=m1+m2+1
∆iÎi log Yi
=
∑m1+m2+N
i=m1+m2+1
∆iÎi
∑m1+m2+N
i=m1+m2+1
ÎiY
κc0
i log Yi∑m1+m2+N
i=m1+m2+1
ÎiY
κc0
i
∑m1+m2+N
i=m1+1
∆i(1− Îi)
κnt
+
m1+m2+N∑
i=m1+1
∆i(1− Îi) log Yi
=
∑m1+m2+N
i=m1+1
∆i(1− Îi)
∑m1+m2+N
i=m1+1
(1− Îi)Y κnti log Yi∑m1+m2+N
i=m1+1
(1− Îi)Y κnti
We run this EM-algorithm until the parameters converge. We choose the start-
ing values as π̃c = m1/(m1 + m2), ρ̃nt and κ̃nt which maximize
∏m1+m2
i=m1+1
Lnti ×
∏m1+m2+N
i=m1+m2+1
(Lnti )
1−π̃c as well as ρ̃c0 and κ̃c0 which maximize
∏m1+m2+N
i=m1+m2+1
(Lc0i )
π̃c .
Then the estimated difference between the survival probability of the compliers in
the treatment group and the survival probability of the compliers in the control
group at a specific time V is given by
Ŵ (V ) = Ŝc1(V )− Ŝc0(V ) = exp (−(ρ̂c1V )κ̂c1)− exp (−(ρ̂c0V )κ̂c0)
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9.3 Nonparametric Empirical Likelihood Estima-
tion
If the parametric assumptions are not correct, then the MLE could be biased.
Therefore, in this section, we propose a nonparametric approach based on empirical
likelihood (Owen, 2001). Under the exclusion restriction (ER) assumption, the
never-takers have the same distribution in both treatment arm and control arm,
so it is natural to incorporate this constraint in the empirical likelihood. However,
this corresponds to an infinite number of estimating equations and leads to poor
performance of empirical likelihood as in the examples in Chapter 10 of Owen
(2001). Instead, we impose a finite subset of the infinite set of constraints as in
Owen (2001). In particular, we impose the constraint that the survival probabilities
of the never-takers at the time point we are focusing on are the same in both arms.
Our approach, which we call plug-in nonparametric empirical maximum likelihood
estimation (PNEMLE), uses three steps to find an approximation to the empirical
maximum likelihood estimator of the difference between the survival probability of
the compliers in the treatment group and that in the control group at a specific time
V subject to the constraints that (a) the survival probabilities of the never-takers in
two arms at the time point we are focusing on are the same and (b) the proportions
of compliers are the same in both arms.
• Step I: Estimate Sc1(V ), Snt(V ) and πc in the treatment group. We estimate
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Sc1(V ), Snt(V ) by Kaplan-Meier estimators Ŝc1(V ), Ŝnt(V ), and we use the
observed fraction of compliers in the treatment group π̂c = Ê(I = 1|R = 1)
to estimate πc.
• Step II: Estimate Sc0(V ) in the control group. We get our estimator Ŝc0(V )
by applying the nonparametric empirical likelihood approach to model the
distribution of the control group with constraints Snt(V ) = Ŝnt(V ) and πc =
π̂c.
• Step III: Estimate W (V ) = Sc1(V ) − Sc0(V ) by Ŵ (V ) = Ŝc1(V ) − Ŝc0(V ),
where Ŝc1(V ) and Ŝc0(V ) are obtained in Step I and Step II.
Since Step I and Step III are straightforward, we only focus on Step II. For j =
1, · · · , n3, let pc0j = P (T = T (3)j | R = 0, I = 1) and pntj = P (T = T (3)j | R = 0, I =
0). Then the empirical likelihood for the observed data in the control group is given
by
Lobs =
m1+m2+N∏
i=m1+m2+1
(π̂cL
1
i + (1− π̂c)L2i ) (9.3.1)
where
L1i = {
n3∑
j=1
pc0j I(T
(3)
j = Yi)}∆i{
n3∑
j=1
pc0j I(T
(3)
j > Yi)}1−∆i
L2i = {
n3∑
j=1
pntj I(T
(3)
j = Yi)}∆i{
n3∑
j=1
pntj I(T
(3)
j > Yi)}1−∆i
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Our constraints are given by
n3∑
j=1
pntj I(T
(3)
j ≥ V ) = Ŝnt(V ) (9.3.2)
n3∑
j=1
pc0j ≤ 1 (9.3.3)
n3∑
j=1
pntj ≤ 1 (9.3.4)
pc0j ≥ 0, j = 1, · · · , n3 (9.3.5)
pntj ≥ 0, j = 1, · · · , n3 (9.3.6)
We want to maximize (9.3.1) under the constraints (9.3.2) - (9.3.6). Since failure
times and censoring times are independent, we can use the hazard function to get
the equivalent form of our optimization problem. For j = 1, · · · , n3, let λj = P (T =
T
(3)
j | T ≥ T (3)j , R = 0, I = 1) and ξj = P (T = T (3)j | T ≥ T (3)j , R = 0, I = 0). Then
the optimization function (9.3.1) with constraints (9.3.2) - (9.3.6) has the equivalent
form
Lobs =
m1+m2+N∏
i=m1+m2+1
(π̂cL
3
i + (1− π̂c)L4i ) (9.3.7)
where
L3i = {
∏
j:T
(3)
j <Yi
(1− λj)−
∏
j:T
(3)
j ≤Yi
(1− λj)}∆i{
∏
j:T
(3)
j ≤Yi
(1− λj)}1−∆i
L4i = {
∏
j:T
(3)
j <Yi
(1− ξj)−
∏
j:T
(3)
j ≤Yi
(1− ξj)}∆i{
∏
j:T
(3)
j ≤Yi
(1− ξj)}1−∆i
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subject to
∏
j:T
(3)
j <V
(1− ξj) = Ŝnt(V ) (9.3.8)
0 ≤ λj ≤ 1, j = 1, · · · , n3 (9.3.9)
0 ≤ ξj ≤ 1, j = 1, · · · , n3 (9.3.10)
We want to use the EM-algorithm to solve this mixture problem. Here, our complete
data likelihood function is given by
Lc =
m1+m2+N∏
i=m1+m2+1
(π̂cL
3
i )
Ii{(1− π̂c)L4i }1−Ii (9.3.11)
E-Step Since the complete data log-likelihood is linear in Ii, the E-step just involves
substituting Îi = Ê(Ii|λ(t)j , ξ(t)j ) into (9.3.11), where for all i = m1+m2+1, · · · ,m1+
m2 + N , Îi is given by
Îi =
π̂cL
3
i
π̂cL3i + (1− π̂c)L4i
(9.3.12)
M-Step After plugging (9.3.12) into (9.3.11), we can get the maximizers of λ and
ξ as below.
(1) Maximizers of λj, ∀j = 1, · · · , n3
For each Yi, we consider it as Îi “subjects” instead of one subject. Let d
c0
j be
the number of failures at T
(3)
j , and r
c0
j be the number of subjects at risk of failure
just prior to T
(3)
j . Then the maximization problem is equivalent to maximizing
n3∏
j=1
λ
dc0j
j (1− λj)r
c0
j −dc0j (9.3.13)
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Therefore, the maximizer of λj is given by
λ̂j = d
c0
j /r
c0
j (9.3.14)
(2) Maximizers of ξi, ∀i = 1, · · · , n3
For each Yi, we consider it as 1− Îi “subjects” instead of one subject. Let dntj be
the number of failures at T
(3)
j , and r
nt
j be the number of subjects at risk of failure
just prior to T
(3)
j . Then our maximization problem is equivalent to maximizing
n3∏
j=1
ξ
dntj
j (1− ξj)r
nt
j −dntj (9.3.15)
subject to
∏
j:T
(3)
j <V
(1− ξj) = Ŝnt(V ) (9.3.16)
0 ≤ ξj ≤ 1, j = 1, · · · , n3 (9.3.17)
We easily use the Lagrange Multiplier method to solve this optimization problem.
The maximizer of ξj is given by
ξ̂j =



dntj
rntj
, if T
(3)
j ≥ V
dntj
rntj −α
, if T
(3)
j < V
(9.3.18)
where α is uniquely obtained by solving
log Ŝnt(V )−
∑
j:T
(3)
j <V
log (1− d
nt
j
rntj − α
) = 0
Theoretical properties in Section 9.5 show that the EM sequence converges to the
unique global maximum no matter where we start our algorithm. One possible
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way to get the initial values is to run the maximization step by assuming Îi =
m1/(m1 +m2). From Theorem 12, the EM sequence converges to the unique global
maximum. We repeat this EM-algorithm until {λ(t)j }n3j=1 and {ξ(t)j }n3j=1 converge.
Assume that {λ(t)j }n3j=1 converge to {λMLEj }n3j=1, and {ξ(t)j }n3j=1 converge to {ξMLEj }n3j=1.
Then the estimator of Sc0(V ) is given by
Ŝc0(V ) =
∏
j:T
(3)
j <V
(1− λMLEj ) (9.3.19)
In summary, our EM-algorithm in Step II is described as below:
E-Step Estimate Ii through (9.3.12).
M-Step Estimate λi and ξi through (9.3.14) and (9.3.18).
9.4 Extension to Trials under Assumptions 1 - 6
In this chapter, we extend our PNEMLE approach to more general trials under
Assumptions 1 - 6 in which the control group has access to the treatment. For
such trials, we have one more compliance class, the always-takers, in addition to
the compliers and the never-takers. If R = 1 and A = 1, we know that the subject
is either a complier or an always-taker; if R = 1 and A = 0, the subject is a never-
taker; if R = 0 and A = 1, the subject is an always-taker; and if R = 0 and A = 0,
the subject is either a complier or a never-taker. The always-takers are identifiable
in the control group and the never-takers are identifiable in the treatment group.
Let Sat(V ), Snt(V ), Sc1(V ) and Sc0(V ) be the survival probability of the always-
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takers, the never-takers, the compliers in the treatment group and the compliers
in the control group at time point V , respectively. We also use πat, πnt and πc to
denote the proportion of the always-takers, the never-takers and the compliers.
Similar to the approach in Section 9.3 of our paper, we follow five steps below
to estimate the difference W (V ) = Sc1(V )− Sc0(V ) for trials under Assumptions 1
- 6.
• Step I: Estimate Sat(V ) and πat from the always-takers (R=0, A=1) in the
control group (R=0). We estimate Sat(V ) by the Kaplan-Meier estimator
Ŝat(V ), and we use the observed fraction of compliers in the treatment group
π̂at = Ê(I = 1|R = 0) to estimate πat.
• Step II: Estimate Snt(V ) and πnt from the never-takers (R=1, A=0) in the
treatment group (R=1). We estimate Snt(V ) by the Kaplan-Meier estimator
Ŝnt(V ), and we use the observed fraction of compliers in the treatment group
π̂nt = Ê(I = 0|R = 1) to estimate πnt.
• Step III: Estimate Sc1(V ) from the mixture of the compliers and the always-
takers (R=1, A=1) in the treatment group (R=1). We get our estimator
Ŝc1(V ) by applying the nonparametric empirical likelihood approach to model
the distribution of the mixture of the compliers and the always-takers in the
control group with constraints Sat(V ) = Ŝat(V ), πat = π̂at and πc = 1− π̂at −
π̂nt.
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• Step IV: Estimate Sc0(V ) from the mixture of the compliers and the never-
takers (R=0, A=0) in the control group (R=0). We get our estimator Ŝc0(V )
by applying the nonparametric empirical likelihood approach to model the
distribution of the mixture of the compliers and the never-takers in the control
group with constraints Snt(V ) = Ŝnt(V ), πnt = π̂nt and πc = 1− π̂at − π̂nt.
• Step V: Estimate W (V ) = Sc1(V ) − Sc0(V ) by Ŵ (V ) = Ŝc1(V ) − Ŝc0(V ),
where Ŝc1(V ) and Ŝc0(V ) are obtained in Step III and Step IV.
9.5 Theoretical Properties of PNEMLE
In this section, we establish theoretical properties of our PNEMLE estimator, which
are proved in Chapter 12.
9.5.1 Existence and Uniqueness
Theorem 11. For any specific time V and plug-in Ŝnt(V ), π̂c, the maximization
problem (9.3.1) under constraints (9.3.2) - (9.3.6) has a unique global maximum.
Proof. See Chapter 12.
9.5.2 Convergence of EM-algorithm
Theorem 12. The EM sequence converges to the unique global maximum of the
maximization problem in Theorem 11.
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Proof. See Chapter 12.
9.5.3 Asymptotic Consistency
We discuss the asymptotic consistency of PNEMLE. For a specific time V , let r
(1)
v ,
r
(2)
v and rGv be the number of subjects at risk of failure just prior to V in compliers
in the treatment group, never-takers in the treatment group and the mixture in the
control group respectively. Let G be the distribution of the mixture in the control
group, that is, G = πcFc0 + (1 − πc)Fnt. We also assume that the distributions of
compliers and never-takers in the control group overlap at least minimally, which
means that the never-takers in the control group can be neither all in the lower
1− πc quantile nor all in the upper 1− πc quantile. This implies that
SG(V )− πc
1− πc I(V≤G
−1(1−πc)) < Snt < 1 +
SG(V )− (1− πc)
1− πc I(V≥G
−1(πc)) (9.5.1)
Asymptotic consistency is shown in the following theorem.
Theorem 13. If (9.5.1) and the conditions below are satisfied
(i) r(1)v →∞, r(2)v →∞, rGv →∞, as m1 + m2 + N →∞
(ii)
m1 + m2
N
→ c, as m1 + m2 + N →∞,where c is a finite constant
(iii) 0 < πc < 1
then we have that
Ŝc1(V )− Ŝc0(V ) P→ Sc1(V )− Sc0(V ), as m1 + m2 + N →∞
Proof. See Chapter 12.
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9.6 Estimation of Confidence Intervals via Boot-
strap Method
PNEMLE provides us a powerful tool to obtain the point estimate of the difference
between the survival probability of compliers in the treatment group and that of
compliers in the control group. However, we are interested in not only the point
estimate but also the confidence interval (CI). Efron and Tibshirani (1994) suggest
using the Bootstrap Method to obtain the confidence interval for censored data
sets {(Yi, ∆i)}m1+m2+Ni=1 . We can construct the CI based on bootstrap percentiles
following the steps below.
• Step I: Draw a Bootstrap sample {(Y ∗i , ∆∗i )}m1+m2+Ni=1 . For compliers in the
treatment group {(Yi, ∆i)}m1i=1, we sample with replacement by putting mass
1
m1
at each point (Yi, ∆i) in order to get Bootstrap sample {(Y ∗i , ∆∗i )}m1i=1. For
never-takers in the treatment group {(Yi, ∆i)}m1+m2i=m1+1, we sample with replace-
ment by putting mass 1
m2
at each point (Yi, ∆i) in order to get Bootstrap sam-
ple {(Y ∗i , ∆∗i )}m1+m2i=m1+1. For mixtures in the control group {(Yi, ∆i)}m1+m2+Ni=m1+m2+1,
we sample with replacement by putting mass 1
N
at each point (Yi, ∆i) in order
to get Bootstrap sample {(Y ∗i , ∆∗i )}m1+m2+Ni=m1+m2+1. We join the three Bootstrap
samples together to get a Bootstrap sample {(Y ∗i , ∆∗i )}m1+m2+Ni=1 .
• Step II: Estimate PNEMLE Ŵ ∗(V ) for this Bootstrap sample following the
procedures in Section 9.3.
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• Step III: Independently repeat steps I and II B times and obtain {Ŵ ∗b (V )}Bb=1.
Find the lower α
2
percentile Ŵ ∗LOW (V ) and the upper
α
2
percentile Ŵ ∗UP (V ).
The (1− α) confidence interval is given by (Ŵ ∗LOW (V ), Ŵ ∗UP (V )).
We can also use the BCa method (a bias corrected version of the bootstrap
percentile method). Please refer to Chapter 12 for details. As we see in Section 9.7,
both types of Bootstrap CIs have reasonably good coverage probability.
9.7 Simulation Studies
In this chapter, we conduct simulation studies to compare our PNEMLE method
to the standard IV estimation and the Weibull parametric estimation under various
outcome distributions (see Table 9.1) and πc = 0.5 (see Table 9.2) or πc = 0.2 (see
Table 9.3). In Table 9.1, the density function of Weibull distribution with ρ and κ is
ρκ(ρx)κ−1 exp (−(ρx)κ), the density function of lognormal distribution with µ and σ
is given by 1
xσ
√
2π
e−(log(x)−µ)
2/2σ2 , the density function of loglogistic distribution with
a and s is given by a(x/s)a/(x(1 + (x/s)a)2), and the density function of gamma
distribution with κ and θ is given by xκ−1 exp (−x/θ)
Γ(κ)θκ
. In all settings, we set the
probability of being assigned to treatment as πc, and results are obtained from 1000
simulated data sets with a sample size of 2K(K = 100 or 200). The administrative
censoring time C is uniformly distributed on the interval [C0, C0 + ∆C]. For each
setting, we consider three values of V : close to zero, in the middle, and close to
C0 + ∆C. We only present results from single consent trials, in which we only have
87
compliers and never-takers in both arms. However, the method can be directly
extended to more general trials.
Before discussing our simulation results, we consider the factors likely to affect
the size of the efficiency gain of our PNEMLE estimator over the standard IV
estimator. Let Cmax denote the maximum censoring time in the control group. The
PNEMLE estimator is Ŝc1(V ) − Ŝc0(V ). Similarly, the standard IV estimator is
written as Ŝc1(V )− S̃c0(V ), where
S̃c0(V ) =
ŜT |R=0(V )− ŜT |R=1(V ) + π̂cŜc1(V )
π̂c
(9.7.1)
(see Imbens and Rubin, 1997). The estimate of Sc0(V ) that PNEMLE uses, Ŝc0(V ),
is always between 0 and 1 because of the constraints applied but the estimate of
Sc0(V ) that standard IV uses, S̃c0(V ), might not be between 0 and 1. When S̃c0(V )
is not between 0 and 1, we expect PNEMLE to be a better estimate than standard
IV because PNEMLE incorporates the knowledge that 0 ≤ Sc0(V ) ≤ 1 whereas
standard IV is implicitly based on an estimate of Sc0(V ) that is not between 0
and 1. For similar reasoning in the non-survival setting, see Imbens and Rubin
(1997) and Cheng et al. (2009b). Three factors which affect the probability that
0 ≤ S̃c0(V ) ≤ 1 are (a) sample size; (b) the time point V and (c) the proportion
of compliers πc. Asymptotically S̃c0(V )
P→ Sc0(V ). Consequently, it is more likely
that S̃c0(V ) escapes from the interval 0 to 1 for small samples. Similarly, S̃c0(V ) is
more likely to escape from [0,1] when Sc0(V ) is near to 0 or near to 1, which will
tend to happen as V gets closer to zero or possibly Cmax. The variance of S̃c0(V ) is
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Table 9.1: Outcome Distributions of the Simulation Studies.
Group Compliers with Treatment Compliers with Control Never-Takers
E Exponential with hazard 0.6 Exponential with hazard 1.5 Exponential with hazard 0.3
W Weibull with ρ = 0.67, κ = 1.2 Weibull with ρ = 2, κ = 0.8 Weibull with ρ = 1, κ = 0.8
LN Lognormal with µ = 2, σ = 1 Lognormal with µ = 3, σ = 1 Lognormal with µ = 1, σ = 1
LL Loglogistic with a = 2, s = 1.5 Loglogistic with a = 1, s = 0.5 Loglogistic with a = 1.5, s = 2
G Gamma with κ = 2, θ = 0.5 Gamma with κ = 3, θ = 0.5 Gamma with κ = 1, θ = 1
approximately proportional to 1
π2c
for fixed sample size, ST |R=1(V ), ST |R=0(V ) and
Sc1(V ), so that S̃c0(V ) is more likely to escape from [0,1] when πc is small. Thus,
we expect PNEMLE to gain more over standard IV for small sample sizes, when
V is closer to the boundaries of [0, Cmax] and when πc is small, because in these
settings, S̃c0(V ) is more likely to escape from [0,1].
Table 9.2 shows the relative biases, i.e., ((estimated-true)/true)*100%, and the
root mean squared errors (RMSE) under various outcome distributions with πc =
0.5. Note that “*” sign in Table 9.2 means that the difference of the RMSEs
between PNEMLE and IV method in that row is significant at 5% level. The
Monte-Carlo estimate of the SE of differences in the RMSE is estimated using the
delta method (see Chapter 12). We see from Table 9.2 that both PNEMLE and
the standard IV method provide approximately unbiased estimates for each V —
the relative bias is at most 11.1% and is much less in most simulation results.
PNEMLE is always at least as efficient as the standard IV method, and PNEMLE
is sometimes much more efficient than the standard IV method, gaining as much
as 28% in RMSE. The gain in efficiency for PNEMLE is bigger when V is close to
zero or C0 + ∆C, and is bigger for the smaller sample size K = 100 than K = 200.
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Weibull parametric estimation provides an approximately unbiased estimator with
smaller RMSE compared to the other two methods when the outcome distribution
is actually Weibull (note that the exponential is a special case of Weibull). However,
it could have large bias and large RMSE when the underlying distribution is not
Weibull. In summary, PNEMLE gives us a more efficient nonparametric estimation
method than the standard IV method and avoids the potential for large bias and
RMSE of a mis-specified parametric model.
To examine the effect of πc on efficiency and bias, we conduct a similar simulation
but change πc from 0.5 to 0.2. Again, “*” sign in Table 9.3 means that the difference
of the RMSEs between PNEMLE and IV method in that row is significant at 5%
level. The Monte-Carlo estimate of the SE of differences in the RMSE is estimated
using the delta method (see Chapter 12). Simulation results in Table 9.3 shows that
PNEMLE has a little more efficiency gain but larger relative bias compared to results
with πc = 0.5 in Table 9.2. Considerable literature on IV estimators for uncensored
outcomes shows that the estimators have a finite sample bias which asymptotically
goes to zero (Nagar, 1959; Bound et al., 1995; Stock et al., 2002). The literature
shows that the finite sample bias is approximately inversely proportional to the
concentration parameter (see discussion below equation (12) in Bound et al., 1995),
which in our setting is 2Kπc
1−πc . This is consistent with the results in Tables 9.2 and 9.3,
where the bias is larger when πc = .2, K = 200 and the concentration parameter is
100 than the bias when πc = .5, K = 100 and the concentration parameter is 200.
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Table 9.2: Estimates of the Difference between Sc1(V ) and Sc0(V ) when πc = 0.5
Relative bias with RMSE with
Group V C0 ∆C K True PNEMLE IV Para PNEMLE IV Para
E
0.1 2 0.2 100 0.081 -0.446 1.45 -6.57 0.0736∗ 0.0757 0.0546
1 2 0.2 100 0.326 -2.13 3.24 1.63 0.143 0.150 0.125
2.1 2 0.2 100 0.241 -8.34 4.03 -3.80 0.107∗ 0.141 0.0854
0.1 2 0.2 200 0.081 -0.909 -0.767 -3.41 0.0508 0.0510 0.0400
1 2 0.2 200 0.326 2.43 2.59 3.17 0.102 0.103 0.0844
2.1 2 0.2 200 0.241 -5.88 -0.563 -3.79 0.0825 0.104 0.0612
W
0.15 2 0.2 100 0.256 -0.313 -3.84 -2.66 0.110∗ 0.124 0.102
1 2 0.2 100 0.363 -0.0141 1.00 1.29 0.133 0.139 0.116
2.05 2 0.2 100 0.186 -6.42 2.10 -5.01 0.0890∗ 0.105 0.0807
0.15 2 0.2 200 0.256 0.608 0.910 -1.25 0.0764 0.0779 0.0676
1 2 0.2 200 0.363 -0.334 -0.262 1.26 0.0928 0.0933 0.0823
2.05 2 0.2 200 0.186 -3.12 0.886 -2.87 0.0629∗ 0.0711 0.0543
LN
4 30 2 100 -0.216 -11.1 6.39 -21.7 0.112∗ 0.155 0.0821
16 30 2 100 -0.370 -0.118 -0.118 0.959 0.124 0.124 0.108
31 30 2 100 -0.256 2.02 2.04 12.4 0.0891 0.0891 0.0898
4 30 2 200 -0.216 -7.04 0.597 -21.9 0.0803 0.0982 0.0659
16 30 2 200 -0.370 1.07 1.07 0.741 0.0906 0.0906 0.0774
31 30 2 200 -0.256 0.243 0.265 12.4 0.0645 0.0645 0.0684
LL
0.04 2.5 0.2 100 0.0734 2.57 6.15 2.44 0.0402 0.0403 0.0310
1 2.5 0.2 100 0.359 1.66 1.85 16.7 0.139 0.141 0.169
2.6 2.5 0.2 100 -0.270 -3.34 1.49 58.0 0.126∗ 0.133 0.128
0.04 2.5 0.2 200 0.0734 1.69 5.06 5.08 0.0275 0.0275 0.0213
1 2.5 0.2 200 0.359 0.366 0.366 14.7 0.0978 0.0978 0.134
2.6 2.5 0.2 200 -0.270 -4.63 -3.51 68.1 0.0888 0.0907 0.104
G
0.4 2 0.2 100 -0.144 -7.53 4.17 1.46 0.110∗ 0.128 0.0934
1 2 0.2 100 -0.271 -1.10 -0.793 3.39 0.143 0.145 0.123
2.1 2 0.2 100 -0.132 1.87 2.06 0.132 0.0974 0.0982 0.0914
0.4 2 0.2 200 -0.144 -6.86 2.50 1.89 0.0687∗ 0.0827 0.0498
1 2 0.2 200 -0.271 1.41 1.41 2.15 0.102 0.102 0.0847
2.1 2 0.2 200 -0.132 2.26 2.45 0.004 0.0717 0.0717 0.0660
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Table 9.3: Estimates of the Difference between Sc1(V ) and Sc0(V ) when πc = 0.2
Relative bias with RMSE with
Group V C0 ∆C K True PNEMLE IV Para PNEMLE IV Para
W
0.15 2 0.2 100 0.256 11.9 45.2 -5.72 0.260∗ 0.604 0.246
1 2 0.2 100 0.363 -14.1 5.56 -10.1 0.270∗ 0.370 0.263
2.05 2 0.2 100 0.186 -33.2 5.71 -25.9 0.207∗ 0.279 0.197
0.15 2 0.2 200 0.256 2.22 17.8 -3.79 0.193∗ 0.339 0.194
1 2 0.2 200 0.363 -7.87 0.703 -6.54 0.203 0.250 0.188
2.05 2 0.2 200 0.186 -19.0 3.54 -13.9 0.142 0.193 0.130
LN
4 30 2 100 -0.216 -59.2 -11.5 -19.4 0.269∗ 0.478 0.115
16 30 2 100 -0.370 3.74 4.12 24.8 0.236 0.257 0.207
31 30 2 100 -0.256 2.69 2.81 25.5 0.170 0.172 0.168
4 30 2 200 -0.216 -30.6 -10.1 -10.2 0.185∗ 0.272 0.0792
16 30 2 200 -0.370 1.64 4.41 21.7 0.173 0.182 0.171
31 30 2 200 -0.256 0.518 0.518 20.7 0.123 0.123 0.130
We conducted a simulation study to check the coverage probability of 95% boot-
strap CI. We set πc = 0.5, K = 100 and simulated 1000 data sets with 2K bootstrap
samples for each data set. Table 9.4 shows that both types of Bootstrap CIs have
reasonably good coverage probability.
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Table 9.4: Coverage Probability of the 95% Bootstrap Confidence Intervals for
PNEMLE
Group V C0 ∆C Percentile BCα
W
0.15 2 0.2 92.5% 93.0%
1 2 0.2 93.5% 92.3%
2.05 2 0.2 91.9% 91.7%
LN
4 30 2 93.7% 94.1%
16 30 2 92.4% 93.1%
31 30 2 95.8% 94.9%
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Chapter 10
Application to HIP Study
The HIP study was a randomized trial that began in 1963 and was aimed at exam-
ining the effects of periodic screening on breast cancer mortality. More than 60,000
women were randomized into two groups at the beginning of the study. Women
in the treatment arm received an initial screening examination and three annual
follow-up visits. Women in the control group received usual care. There is a lot of
literature studying this data set. Joffe (2001) uses G-estimation of the accelerated
failure time model (AFTM) with artificial censoring to analyze the data and con-
cluded that screening increased the mean time to death from breast cancer by 22%
with 95% confidence interval (5.1%, 63.2%). However, this approach depends on a
parametric model for how the treatment affects failure time for its validity. Baker
(1998) extends the noncompliance setting to survival outcomes and estimated that
screening saved $16, 000 cost-effectiveness per life year with 95% confidence inter-
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val ($10, 000, $51, 000). Baker’s estimate is equivalent to the standard IV estimate.
Similar to Joffe (2001), we consider the first 10 years of each woman’s follow-up, be-
cause this reduces the attenuation of the effects of the screening in the initial three
years by later periods in which both groups receive the same treatments. There-
fore, the administrative censoring times for all subjects are 10 years in our study.
Furthermore, we follow Baker (1998) in conducting a limited mortality analysis by
only considering data from subjects whose breast cancer was diagnosed within the
first 7 years of study. Note that our sample is different from the samples of Joffe
and Baker because we combine their sample selection rules. We provide estimates
of the difference of survival probability of compliers in the treatment group and
that in the control group for every half year as well as the 95% confidence intervals.
In the left panel of Figure 10.1, we show the results of PNEMLE (cross, with solid
line confidence interval) and the standard IV (circle, with dashed line confidence
interval). For the right panel of Figure 10.1, we show the results of Parametric
Weibull (cross, with solid line confidence interval) and ITT (circle, with dashed line
confidence interval). We contrast PNEMLE with several other approaches. From
the left Panel of Figure 10.1, we find that both PNEMLE and standard IV provide
similar estimates and CIs at each time point. The 95% CIs are strictly above zero
after 4 years, which means that there is strong evidence that the treatment has a
beneficial effect for compliers after 4 years. Compliers who received treatment have
12.3% (4.08%, 20.6%) higher probability to survive over 10 years than those who
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Figure 10.1: Results from HIP study.
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received control. The right Panel of Figure 10.1 shows the parametric estimates
under Weibull assumption and the intent-to-treat (ITT) estimates as well as 95%
CIs. The parametric estimator would be more efficient if we knew that the un-
derlying distribution of failure times is Weibull. However, from the discussion in
Chapter 12, there is evidence to cast doubt on the validity of the Weibull model
for never-takers in the treatment arm. The ITT estimates the effect of assignment
to treatment on survival in contrast to the PNEMLE which estimates the effect
of actually receiving treatment on survival. The ITT estimates are substantially
smaller than the PNEMLE estimates, meaning that there is a substantial amount
of noncompliance.
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Chapter 11
Conclusion
In this paper, we develop a more efficient nonparametric method than the standard
IV to estimate the difference between the survival probability of the compliers in
the treatment group and that in the control group at some specific time. PNEMLE
does not rely on parametric assumptions, which is an advantage over the para-
metric method and accelerated failure time model. An interesting problem for
future work is to estimate the whole distribution of potential failure times through
a nonparametric approach. In addition, under the current setting, we assume that
distributions of censoring times and failure times are independent. Estimation of
the causal effect under dependence is a potential research topic for further studies.
The first step is to extend this method to the cases when censoring is at random
given baseline covariates. It will also be important to investigate the cases where the
probability of the compliance depends on a baseline covariate such as co-morbidity.
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Chapter 12
Proofs and Supplementary
Materials
Proof of Theorem 11
Proof. We prove this theorem by showing that it is a convex optimization prob-
lem. The maximization problem (9.3.1) under the constraints (9.3.2) - (9.3.6) is
equivalent to minimizing
− log Lobs =
m1+m2+N∑
i=m1+m2+1
− log (π̂cL1i + (1− π̂c)L2i ) (12.0.1)
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subject to
n3∑
j=1
pntj I(T
(3)
j ≥ V ) = Ŝnt(V ) (12.0.2)
−1 +
n(3)∑
j=1
pc0j ≤ 0 (12.0.3)
−1 +
n(3)∑
j=1
pntj ≤ 0 (12.0.4)
−pc0j ≤ 0, j = 1, · · · , n3 (12.0.5)
−pntj ≤ 0, j = 1, · · · , n3 (12.0.6)
Here, L1i and L
2
i are the same as before.
Let x = (pc01 , · · · , pc0n3 , pnt1 , · · · , pntn3). Then note that
• π̂cL1i + (1− π̂c)L2i is a linear function of x and hence is a concave function
• −log(z) is strictly convex and decreasing
• Summation preserves convexity
Then according to Boyd and Vandenberghe (2004, Chapter 3), we have that our
objective function (12.0.1) is strictly convex.
Moreover, for our constraints (12.0.2) - (12.0.6), we have that
• The inequality constraint functions in (12.0.3) - (12.0.6) are all linear functions
of x and hence are convex functions
• The equality constraint function (12.0.2) is a linear combination of x and thus
is affine
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Therefore, our maximization problem is a strictly convex optimization problem.
Hence, according to Boyd and Vandenberghe (2004, Chapter 4), it has a unique
global maximum.
Proof of Theorem 12
Proof. The proof for this theorem is similar to that of Lemma 1 in Cheng, Small,
Tan and Ten Have (2009b). There are two major differences. One is that our
optimization problem is given by (12.0.1) - (12.0.6), however, like Cheng et al.
(2009b), our problem is also a convex optimization problem. The other is that our
constraint parameter space is given by Θ = {pc0i , pnti , i = 1, · · · , n3 : qi = π̂cpc0i +
(1 − π̂c)pnti ,
∑
i p
nt
i I(T
(3)
i ≥ V ) = Ŝnt(V ),
∑
i p
nt
i ≤ 1,
∑
i p
c0
i ≤ 1, pnti ≥ 0, pc0i ≥ 0}.
The set Θ, as in Cheng et al. (2009b), is a convex set because the feasible set of
a convex optimization problem is also convex. Because our optimization problem
is convex and the constraint parameter space is a convex set, we follow the same
steps as in Cheng et al. (2009b) to prove the theorem.
Proof of Theorem 13
Proof. Step 1
From Kaplan and Meier (1958), under the conditions r
(1)
v → ∞ and r(2)v → ∞,
we know that, as m1 + m2 + N →∞,
Ŝc1(V )
P→ Sc1(V ) (12.0.7)
Ŝnt(V )
P→ Snt(V ) (12.0.8)
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By the Law of Large Numbers, as m1 + m2 + N →∞,
π̂c
a.s.→ πc (12.0.9)
Step 2
Let qKPi =
dGi
rGi
∏i−1
j=1(1−
dGj
rGj
), which is the Kaplan-Meier estimator of the mixture
in the control group. Consider the conditions (9.3.2) - (9.3.6) along with
π̂cp
c0
i + (1− π̂c)pnti = qKPi (12.0.10)
Here, notice that with (9.3.3) - (9.3.6) and (12.0.10), sometimes (9.3.2) cannot
be satisfied. Given (9.3.3) - (9.3.6) and (12.0.10), we want to find the lower bound
ŜLnt(V ) and upper bound Ŝ
M
nt (V ) of
∑n3
j=1 p
nt
j I(T
(3)
j ≥ V ).
Define l = sup{i : ∑i−1j=1
qKPj
1−π̂c ≤ 1}, then
pnt,Li =



qKPi
1−π̂c , i = 1, · · · , l − 1
1−∑l−1j=1
qKPj
1−π̂c , i = l
0, i = l + 1, · · · , n3
and
ŜLnt(V ) =
n3∑
j=1
pnt,Lj I(T
(3)
j ≥ V )
Define m = inf{i : ∑n3j=i+1
qKPj
1−π̂c ≤ 1}, then
pnt,Mi =



0, i = 1, · · · ,m− 1
1−∑n3j=m+1
qKPj
1−π̂c , i = m
qKPi
1−π̂c , i = m + 1, · · · , n3
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and
ŜMnt (V ) =
n3∑
j=1
pnt,Mj I(T
(3)
j ≥ V )
Therefore,
∑n3
j=1 p
nt
j I(T
(3)
j ≥ V ) ∈ [ŜLnt(V ), ŜMnt (V )]
Similarly, define l̃ = sup{i : ∑i−1j=1
qKPj
1−πc ≤ 1}, then
pnt,L̃i =



qKPi
1−πc , i = 1, · · · , l̃ − 1
1−∑l̃−1j=1
qKPj
1−πc , i = l̃
0, i = l̃ + 1, · · · , n3
and
S̃Lnt(V ) =
n3∑
j=1
pnt,L̃j I(T
(3)
j ≥ V )
Define m̃ = inf{i : ∑n3j=i+1
qKPj
1−πc ≤ 1}, then
pnt,M̃i =



0, i = 1, · · · , m̃− 1
1−∑n3j=m̃+1
qKPj
1−πc , i = m̃
qKPi
1−πc , i = m̃ + 1, · · · , n3
and
S̃Mnt (V ) =
n3∑
j=1
pnt,M̃j I(T
(3)
j ≥ V )
We want to show that, as m1 + m2 + N →∞,
ŜLnt(V )− S̃Lnt(V ) a.s.→ 0
ŜMnt (V )− S̃Mnt (V ) a.s.→ 0
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Since
|ŜLnt(V )− S̃Lnt(V )|
= |
n3∑
j=1
pnt,Lj I(T
(3)
j ≥ V )−
n3∑
j=1
pnt,L̃j I(T
(3)
j ≥ V )|
≤ |
min{l,l̃}∑
j=1
pnt,Lj I(T
(3)
j ≥ V )−
min{l,l̃}∑
j=1
pnt,L̃j I(T
(3)
j ≥ V )|
+|
max{l,l̃}∑
j=min{l,l̃}+1
pnt,Lj I(T
(3)
j ≥ V )−
max{l,l̃}∑
j=min{l,l̃}+1
pnt,L̃j I(T
(3)
j ≥ V )|
where
∑c
j=b aj = 0 if b > c.
Note that if π̂c ≥ πc, then l ≤ l̃. We get that
min{l,l̃}∑
j=1
pnt,Lj I(T
(3)
j ≥ V )−
min{l,l̃}∑
j=1
pnt,L̃j I(T
(3)
j ≥ V )
= (
1
1− π̂c −
1
1− πc )
l∑
j=1
qKPj I(T
(3)
j ≥ V )
+(1− 1
1− π̂c
l∑
j=1
qKPj )I(T
(3)
l ≥ V )
Similarly, if π̂c < πc, then l ≥ l̃. We also get that
min{l,l̃}∑
j=1
pnt,Lj I(T
(3)
j ≥ V )−
min{l,l̃}∑
j=1
pnt,L̃j I(T
(3)
j ≥ V )
= (
1
1− π̂c −
1
1− πc )
l̃∑
j=1
qKPj I(T
(3)
j ≥ V )
−(1− 1
1− πc
l̃∑
j=1
qKPj )I(T
(3)
l̃
≥ V )
103
Therefore, combining these two situation, we get that
|
min{l,l̃}∑
j=1
pnt,Lj I(T
(3)
j ≥ V )−
min{l,l̃}∑
j=1
pnt,L̃j I(T
(3)
j ≥ V )|
= |max{ 1
1− π̂c −
1
1− πc ,
1
1− πc −
1
1− π̂c}
min{l,l̃}∑
j=1
qKPj I(T
(3)
j ≥ V )
+(1−max{ 1
1− π̂c ,
1
1− πc}
min{l,l̃}∑
j=1
qKPj )I(T
(3)
min{l,l̃} ≥ V )|
≤ |( 1
1− π̂c −
1
1− πc )
min{l,l̃}∑
j=1
qKPj |+ |1−
min{l,l̃}∑
j=1
qKPj max{
1
1− π̂c ,
1
1− πc}|
From (12.0.9), we know that | 1
1−π̂c − 11−πc |
a.s.→ 0. And from the fact that
|∑min{l,l̃}j=1 qKPj | ≤ 1,
|( 1
1− π̂c −
1
1− πc )
min{l,l̃}∑
j=1
qKPj | a.s.→ 0
For the second part, from definitions, it is easy to verify that
min{1− π̂c, 1− πc} ≤
min{l,l̃}∑
j=1
qKPj ≤ max{1− π̂c, 1− πc}
Thus,
1−max{1− π̂c
1− πc ,
1− πc
1− π̂c} ≤ 1−
min{l,l̃}∑
j=1
qKPj max{
1
1− π̂c ,
1
1− πc} ≤ 0
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Therefore,
|1−
min{l,l̃}∑
j=1
qKPj max{
1
1− π̂c ,
1
1− πc}|
≤ |1−max{1− π̂c
1− πc ,
1− πc
1− π̂c}|
= |1− 1−min{π̂c, πc}
1−max{π̂c, πc}|
Again, from (9) and the condition that 0 < πc < 1, we know that
|1−
min{l,l̃}∑
j=1
qKPj max{
1
1− π̂c ,
1
1− πc}|
a.s.→ 0
Hence,
|
min{l,l̃}∑
j=1
pnt,Lj I(T
(3)
j ≥ V )−
min{l,l̃}∑
j=1
pnt,L̃j I(T
(3)
j ≥ V )| a.s.→ 0
Next, if π̂c ≥ πc, then l ≤ l̃. We also get that
|
max{l,l̃}∑
j=min{l,l̃}+1
pnt,Lj I(T
(3)
j ≥ V )−
max{l,l̃}∑
j=min{l,l̃}+1
pnt,L̃j I(T
(3)
j ≥ V )|
=
l̃∑
j=l+1
pnt,L̃j I(T
(3)
j ≥ V )
≤
l̃∑
j=l+1
pnt,L̃j
= 1−
∑l
j=1 q
KP
j
1− πc
From the definitions of l, l̃ and the fact that π̂c ≥ πc, we get that
1− π̂c ≤
l∑
j=1
qKPj ≤ 1− πc
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Therefore,
|
max{l,l̃}∑
j=min{l,l̃}+1
pnt,Lj I(T
(3)
j ≥ V )−
max{l,l̃}∑
j=min{l,l̃}+1
pnt,L̃j I(T
(3)
j ≥ V )|
≤ 1−
∑l
j=1 q
KP
j
1− πc
≤ 1− 1− π̂c
1− πc
If π̂c < πc, then l̃ ≤ l. We get that
|
max{l,l̃}∑
j=min{l,l̃}+1
pnt,Lj I(T
(3)
j ≥ V )−
max{l,l̃}∑
j=min{l,l̃}+1
pnt,L̃j I(T
(3)
j ≥ V )|
=
l∑
j=l̃+1
pnt,Lj I(T
(3)
j ≥ V )
≤
l∑
j=l̃+1
pnt,Lj
= 1−
∑l̃
j=1 q
KP
j
1− π̂c
Again, from the definitions of l, l̃ and the fact that π̂c ≥ πc, we get that
1− πc ≤
l̃∑
j=1
qKPj ≤ 1− π̂c
Therefore,
|
max{l,l̃}∑
j=min{l,l̃}+1
pnt,Lj I(T
(3)
j ≥ V )−
max{l,l̃}∑
j=min{l,l̃}+1
pnt,L̃j I(T
(3)
j ≥ V )|
≤ 1−
∑l̃
j=1 q
KP
j
1− π̂c
≤ 1− 1− πc
1− π̂c
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Combining these two case, we get that
|
max{l,l̃}∑
j=min{l,l̃}+1
pnt,Lj I(T
(3)
j ≥ V )−
max{l,l̃}∑
j=min{l,l̃}+1
pnt,L̃j I(T
(3)
j ≥ V )|
≤ 1− min{1− πc, 1− π̂c}
max{1− πc, 1− π̂c}
= 1− 1−max{πc, π̂c}
1−min{πc, π̂c}
From (12.0.9) and the condition that 0 < πc < 1, we know that
|
max{l,l̃}∑
j=min{l,l̃}+1
pnt,Lj I(T
(3)
j ≥ V )−
max{l,l̃}∑
j=min{l,l̃}+1
pnt,L̃j I(T
(3)
j ≥ V )| a.s.→ 0
To sum up, we verify that
ŜLnt(V )− S̃Lnt(V ) a.s.→ 0
Similarly, we can also prove that
ŜMnt (V )− S̃Mnt (V ) a.s.→ 0
Step 3
In this step, we would like to show that, as m1 + m2 + N →∞,
S̃Lnt(V )
P→ SG(V )− πc
1− πc IV≤G
−1(1−πc) (12.0.11)
S̃Mnt (V )
P→ 1 + SG(V )− (1− πc)
1− πc IV≥G
−1(πc) (12.0.12)
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As m1 + m2 + N →∞,
S̃Lnt(V ) =
n3∑
j=1
pnt,L̃j I(T
(3)
j ≥ V )
=
l̃−1∑
j=1
qKPj
1− πc I(T
(3)
j ≥ V ) + pl̃I(T (3)l̃ ≥ V )
P→ (1− πc)− (1− SG(V ))
1− πc I(V≤G
−1(1−πc))
=
SG(V )− πc
1− πc I(V≤G
−1(1−πc))
Similarly,
S̃Mnt (V )
P→ 1 + SG(V )− (1− πc)
1− πc I(V≥G
−1(πc))
Step 4
From (9.5.1) which is given by
SG(V )− πc
1− πc I(V≤G
−1(1−πc)) < Snt < 1 +
SG(V )− (1− πc)
1− πc I(V≥G
−1(πc))
, along with (12.0.8), (12.0.11) and (12.0.12), we verify that, as m1 +m2 +N →∞,
SG(V )− πc
1− πc I(V≤G
−1(1−πc)) ≤
n3∑
j=1
pntj I(T
(3)
j ≥ V ) ≥ 1 +
SG(V )− (1− πc)
1− πc I(V≥G
−1(πc))
is asymptotically valid in probability. Hence, (9.3.2) is asymptotically satisfied in
probability under maximization constraints (9.3.3) - (9.3.6) and (12.0.10). There-
fore, the maximization problem (9.3.1) under constraints (9.3.2) - (9.3.6) in the
paper is asymptotically equivalent to the maximization problem (9.3.1) under con-
straints (9.3.3) - (9.3.6) and (12.0.10) in probability. Note that qKPi in (12.0.10) is
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actually the Kaplan-Meier estimator of the mixture in the control group. Therefore,
from Kaplan and Meier (1958), since rGv →∞, as m1 +m2 +N →∞, we have that
ŜG(V )
P→ SG(V ) (12.0.13)
Step 5
From (12.0.8), (12.0.9), (12.0.13) and the fact that ŜG(V ),Ŝnt(V ),π̂c are all
bounded, we get that
Ŝc0(V ) =
ŜG(V )− π̂cŜnt(V )
1− π̂c
P→ SG(V )− πcSnt(V )
1− πc
= Sc0(V )
Hence, along with (12.0.7), we verify that
Ŝc1(V )− Ŝc0(V ) P→ Sc1(V )− Sc0(V )
Standard Errors Calculation through Delta Method
The difference of the RMSEs of two estimators δ1 and δ2 are defined as:
T =
√
E((δ1 − θ)2)−
√
E((δ2 − θ)2)
Therefore, we can get the variance of T as below:
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V ar(T ) = σ2δ1(
∂T
∂δ1
)2 + σ2δ2(
∂T
∂δ2
)2 + 2σδ1δ2(
∂T
∂δ1
)(
∂T
∂δ2
)
= σ2δ1(
E(δ1 − θ)√
E((δ1 − θ)2)
)2 + σ2δ2(
E(δ2 − θ)√
E((δ2 − θ)2)
)2
+2σδ1δ2(
E(δ1 − θ)√
E((δ1 − θ)2)
)(
E(δ2 − θ)√
E((δ2 − θ)2)
)
From Delta method, we can estimate the standard error of T as
V ar(T ) = ˆV ar(δ1)(
ˆBias(δ1)
ˆRMSE(δ1)
)2 + ˆV ar(δ2)(
ˆBias(δ2)
ˆRMSE(δ2)
)2
+ 2 ˆCov(δ1, δ2)(
ˆBias(δ1)
ˆRMSE(δ1)
)(
ˆBias(δ2)
ˆRMSE(δ2)
)
where ˆV ar(δ1) and ˆV ar(δ2) are sample variances of δ1 and δ2, ˆCov(δ1, δ2) is the
sample covariance, ˆBias(δ1) and ˆBias(δ2) are sample biases, as well as ˆRMSE(δ1)
and ˆRMSE(δ2) are sample RMSEs. All of the above quantities are available
through the simulation studies.
Test for Parametric Weibull Assumption
We will give the detailed discussion on whether the potential failure times of
compliers and never-takers in our limited mortality analysis of the HIP data set
follow the Weibull distribution. From Cox and Oakes (1984), if T follows the Weibull
distribution with density function ρκ(ρx)κ−1 exp (−(ρx)κ), it is easy to verify that
log(H(t)) = κ log(ρ) + κ log(t),
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where H(t) is the cumulative hazard function of T . Therefore, log(H(t)) and log(t)
should have a linear relationship when T follows a Weibull distribution. We es-
timate log(H(t)) by log(Ĥ(t)) through the Kaplan-Meier estimator. Figure 12.1
shows us the result for compliers in the treatment arm. The mean squared error
(MSE) for the regression between log(Ĥ(t)) and log(t) is 0.0306. We use this MSE
as a test statistic for testing that T follows a Weibull distribution and use the para-
metric Bootstrap method to perform the test. If we assume that the failure times
of compliers in the treatment arm follow a Weibull distribution with parameters
κc1 and ρc1, the MLEs for κc1 and ρc1 are given by κ̂c1 = 1.939 and ρ̂c1 = 0.579.
We generate random samples for Weibull distribution with parameters κ̂c1 = 1.939
and ρ̂c1 = 0.579, calculate log(Ĥ(t)) through the Kaplan-Meier method, fit the lin-
ear regression between log(Ĥ(t)) and log(t), and get the MSE for this regression.
We repeat this procedure 10,000 times. The estimated p-value is given by 0.1858.
Therefore, there is not strong evidence for us to reject the null hypothesis that
the failure times of compliers in the treatment group follow the Weibull distribu-
tion. However, from Figure 12.2 which shows us the result for never-takers in the
treatment arm, it does not reveal a strong linear pattern between log(Ĥ(t)) and
log(t). The MSE for the regression between log(Ĥ(t)) and log(t) is 0.0924. If we
assume that the failure times of compliers in the treatment arm follow a Weibull
distribution with parameters κnt and ρnt, the MLEs for κnt and ρnt are given by
κ̂nt = 1.202 and ρ̂nt = 0.444. We follow the same approach as above to conduct
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Figure 12.1: Compliers in the Treatment Arm
the hypothesis testing, and the estimated p-value is given by 0.0418. Thus, there is
evidence for us to cast doubts on the validity of the Weibull model for never-takers
in the treatment arm.
Details of BCa method
Besides Bootstrap percentile method, Efron and Tibshirani (1994) suggest using
BCa method to obtain the confidence interval for censored data sets {(Yi, ∆i)}m1+m2+Ni=1 .
We can construct the BCa confidence interval following the steps below.
• Step I: Draw a Bootstrap sample {(Y ∗i , ∆∗i )}m1+m2+Ni=1 . For compliers in the
treatment group {(Yi, ∆i)}m1i=1, we sample with replacement by putting mass
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Figure 12.2: Never-takers in the Treatment Arm
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1
m1
at each point (Yi, ∆i) in order to get Bootstrap sample {(Y ∗i , ∆∗i )}m1i=1. For
never-takers in the treatment group {(Yi, ∆i)}m1+m2i=m1+1, we sample with replace-
ment by putting mass 1
m2
at each point (Yi, ∆i) in order to get Bootstrap sam-
ple {(Y ∗i , ∆∗i )}m1+m2i=m1+1. For mixtures in the control group {(Yi, ∆i)}m1+m2+Ni=m1+m2+1,
we sample with replacement by putting mass 1
N
at each point (Yi, ∆i) in or-
der to get Bootstrap sample {(Y ∗i , ∆∗i )}m1+m2+Ni=m1+m2+1. We join three Bootstrap
samples together to get a Bootstrap sample {(Y ∗i , ∆∗i )}m1+m2+Ni=1 .
• Step II: Estimate PNEMLE Ŵ ∗(V ) for this Bootstrap sample following the
procedures in Section 9.3.
• Step III: Independently repeat steps I and II B times and obtain {Ŵ ∗b (V )}Bb=1.
Find the lower α1 percentile Ŵ
∗
LOW (V ) and the upper α2 percentile Ŵ
∗
UP (V ),
where α1 and α2 are given as
α1 = Φ(ẑ0 +
ẑ0 + z
(α)
1− α̂(ẑ0 + z(α)))
α2 = Φ(ẑ0 +
ẑ0 + z
(1−α)
1− α̂(ẑ0 + z(1−α)))
The value of ẑ0 is obtained directly from the proportion of Bootstrap replica-
tions less than the original estimate Ŵ (V ), that is,
ẑ0 = Φ
−1(
No. of {Ŵ ∗b (V ) < Ŵ (V )}
B
)
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Let Ŵ(.)(V ) =
∑B
b=1 Ŵ
∗
b (V )
B
. The value of α̂ is obtained from
α̂ =
∑B
b=1(Ŵ(.)(V )− Ŵb(V ))3
6(
∑B
b=1(Ŵ(.)(V )− Ŵb(V ))2)
3
2
• Step IV: The (1− 2α) confidence interval is given by (Ŵ ∗LOW (V ), Ŵ ∗UP (V )).
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